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ABSTRACT 
 
 Thiamin pyrophosphate is an essential cofactor in all living systems. Its 
biosynthesis involves two separate pathways to synthesize pyrimidine and thiazole, 
followed by a coupling of these two heterocycles to generate thiamin. In this 
dissertation, the Bacillus subtilis thiazole synthase (ThiG) and Candida albicans 
pyrimidine synthase (THI5p) were investigated.  
The unanticipated reverse reaction of ThiG and the thiazole tautomer generated 
an intermediate, which was characterized by mass spectrometry and further applied to 
investigate the later steps of thiazole biosynthesis involving ThiG and ThiO, which is the 
glycine oxidase. This study demonstrated our proposed mechanism of B. subtilis thiazole 
biosynthesis involving ThiG and ThiO.  
The THI5 protein (THI5p) was reconstituted in vitro and identified as a single 
turnover protein to use an active-site histidine to react with pyridoxal 5’-phosphate 
(PLP) to generate HMP-P. The histidine structure after HMP-P formation was 
characterized as a keto-acid. The PLP by-products were trapped by phenylhydrazine 
derivatization. The structural characterization identified as glyoxylate via C3-fragment. 
The keto-acid, C3-fragment and glyoxylate had oxygen incorporations from O2. The 
pattern of incorporations suggested that the protein utilized multiple O2 to synthesize 
HMP-P. Moreover, a shunt product, PLP-nitrile, was identified to suggest that the 
reaction was initiated by a radical reaction. Based on these preliminary information, a 
mechanism was proposed. To investigate the proposed mechanism, phosphopeptide 
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enrichment was used to identify the peptides containing possible shunt intermediates. 
The investigations could help to test the proposed mechanism. 
Because THI5p required Fe(II) and O2 to catalyze HMP-P synthesis, preliminary 
bioinorganic investigations were conducted by oxygen consumption measurements, 
EPR, and UV-Vis spectra. The results suggested that the protein used multiple O2 and 
might be a diiron protein. All of the information could serve as a stepping stone for 
future studies. 
 All of the investigations could help us to understand how nature designs THI5p 
to be a single turnover protein to synthesize HMP-P without chemical and biochemical 
precedent. 
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CHAPTER I 
 INTRODUCTION 
 
Thiamin 
Thiamin pyrophosphate (TPP) is an essential cofactor in all living systems 1-3. 
Bacteria, fungi, and plants all possess the biosynthetic machinery to produce it, but 
animals must obtain it through their diets. Its biosynthesis involves two separate 
pathways to synthesize pyrimidine and thiazole, followed by a coupling of these two 
heterocycles to generate thiamin (Figure 1-1). But thiamin biosynthesis is not uniform 
across all species, prokaryotes and eukaryotes involve different enzymes and use 
different starting materials to generate the same product. 
 
 
Figure 1-1. The formation of thiamin from pyrimidine and thiazole. 
 
 
Biosynthesis of thiamin thiazole in prokaryotes 
In bacteria, the thiazole moiety is biosynthesized by ThiG 4-6. The early steps in 
thiazole biosynthesis in Bacillus subtilis have been studied extensively and the 
mechanism is proposed (Figure 1-2). The thiazole of thiamin is biosynthesized via a 
lysine residue of the thiazole synthase, ThiG, forming an imine with 1-deoxy-D-
N
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COOH
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xylulose-5-phosphate 1-1 (DXP). The imine tautomerizes to form aminoketone 1-3. The 
thiocarboxylate of ThiS 1-4 attacks the ketone of 1-3 followed by an S/O acyl shift to 
generate 1-6 after loss of water. Subsequent elimination of ThiS forms 1-7. The glycine 
imine 1-9 produced by the ThiO-catalyzed oxidation of glycine 1-8 is attacked by the 
thiol of 1-7 to generate 1-10. Transimination followed by elimination of ThiG cyclizes 
1-10 to afford the thiazole tautomer 1-11 7. The thiazole tautomer undergoes 
aromatization to form 1-12. 
 
 
Figure 1-2. Mechanistic proposal for the formation of the thiamin thiazole in bacteria. 
 
 
In chapter 2, I will discuss the reaction of the thiazole tautomer 1-11 with ThiG 
to undergo the reverse reaction to form 1-7. The intermediate 1-7 was trapped by NaBH4 
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reduction followed by SDS-PAGE analysis and identified by phosphoprotein stain and 
protein mass spectrometry. Furthermore, the formation of 1-7 can be used to investigate 
the later steps of thiazole biosynthesis involving the ThiO-catalyzed reaction. Isotope-
labeled substrates were used to demonstrate the reconstitution. 
 
Biosynthesis of thiamin pyrimidine in eukaryotes 
In prokaryotes, the pyrimidine moiety, 4-amino-2-methyl-5-hydroxymethyl 
pyrimidine (HMP), is synthesized from 5-aminoimidazole ribonucleotide 1-13 (AIR), 
which is an intermediate in purine biosynthesis (Figure 1-3). The synthesis involves a 
complicated rearrangement that occurs via a radical reaction catalyzed by the radical 
SAM enzyme, ThiC 8. 
 
 
Figure 1-3. Biosynthesis of the HMP moiety of thiamin in prokaryotes and eukaryotes. 
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In eukaryotes, the biosynthetic pathway of the pyrimidine is still under 
investigation (Figure 1-3). Genetic knockout experiments in Saccharomyces cerevisiae 
have shown that the THI5 gene family is involved in thiamin pyrimidine synthesis 9. 
Feeding experiments and in vivo labeling studies have suggested that the pyrimidine 
moiety is generated from histidine 1-14 10 and pyridoxine 1-15 11. The in vivo labeling 
experiments indicated C-2, C-2’, N-1, C-5, C-5’, and C-6 in the pyrimidine are from 
pyridoxine. Furthermore, the THI5 gene is adjacent to SNO and SNZ, putative pyridoxal-
5’-phosphate (PLP) biosynthetic genes 12. Therefore, PLP could be a direct precursor for 
pyrimidine biosynthesis in eukaryotes. Alternatively, the addition of 14N-labeled 
histidine in 15N-growth media decreased 15N-incorporation in the pyrimidine of thiamin 
in S. cerevisiae 13. Thus, histidine is proposed to be a direct precursor for the nitrogen 
atom of the thiamin pyrimidine moiety (Figure 1-4). Based on feeding studies, N-1, C-2, 
and N-3 of the imidazole ring in histidine incorporate at N-3, C-4, and amino-N at C-4 
of the pyrimidine. Specifically, the N-3 of the pyrimidine is derived from N-1 of the 
imidazole ring in histidine, as demonstrated by incorporation of the 15N-amino group 
from aspartate, the origin of N-1 in histidine. 
 
 
Figure 1-4. Atom incorporation patterns of histidine and PLP fragments into HMP-P. 
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In chapter 3 to 7, the investigation of HMP-P synthesis catalyzed by THI5p was 
conducted. The reconstitution of THI5p was achieved to investigate the mechanism. 
THI5p is a single turnover protein in which His66 in the active site reacts with PLP via 
the imine formation of Lys62. After HMP-P formation, His66 becomes a keto-acid with 
two oxygen incorporations derived from O2. The PLP by-product is glyoxylate with 
oxygen incorporations. The intermediate investigations were developed and the 
proposed structures were made based on the LC-MS analysis. Moreover, bioinorganic 
investigations of THI5p were conducted to initiate future studies. 
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CHAPTER II 
 THE BACTERIAL THIAZOLE SYNTHASE:  
TRAPPING OF A COVALENT INTERMEDIATE 
 
Introduction  
The biosynthesis of thiamin pyrophosphate (TPP) biosynthesis involves two 
separate pathways to synthesize pyrimidine and thiazole. These two heterocycles are 
coupled together to generate thiamin 2-14. In Bacillus subtilis, the formation of thiazole 
is catalyzed by the thiazole synthase, ThiG, using 1-deoxy-D-xylulose-5-phosphate 
(DXP) 2-1 as starting material to react with thiocarboxylate 2-4 and glycine imine 2-9 
(Figure 2-1). In this biosynthesis, the five additional enzymes, ThiF, ThiS, ThiO, ThiI, 
and NifS, are required to participate in this complex condensation.  
 
 
Figure 2-1. The proposed mechanism for the formation of thiamin in B. subtilis. 
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The in vitro reconstitution of B. subtilis thiazole biosynthesis was achieved. ThiG 
generates the thiazole tautomer 2-11 as the product. Recently, a thiazole tautomerase, 
TenI, has been identified to aromatize 2-11 to carboxylthiazole 2-12 7. Finally ThiE 
catalyzes the coupling reaction of 2-12 and HMP-PP 2-13 to generate thiamin. In this 
study, the intermediate 2-7 in thiazole biosynthesis in B. subtilis was identified. It was 
generated by the unanticipated reverse reaction of ThiG and the thiazole tautomer 2-11. 
Furthermore, this intermediate 2-7 was applied to react with the glycine imine 2-9 
generated by the ThiO-catalyzed glycine oxidation. The isotope-labeled glycine imine  
2-9 was further used to investigate the later steps of thiazole biosynthesis involving ThiG 
and ThiO. 
 
 
Experimental methods 
Preparation of thiazole tautomer 6,14  
 E. coli BL21(DE3) cells containing the overexpression plasmid (THI4p in a 
pET28 vector) was grown in LB medium containing kanamycin with shaking at 37 °C 
until OD600 reached 0.2 to 0.3. At this moment, THI4p overexpression was induced with 
IPTG (final concentration of 2 mM), and cell growth was continued at 15 °C for 16 h. 
The cells were harvested by centrifugation at 5000 rpm for 10 min and the resulting 
pellets were stored at -80 °C until protein purification. 
 To purify THI4p, the cell pellets were resuspended in lysis buffer (10 mM 
imidazole, 300 mM NaCl, 50 mM NaH2PO4, pH 8) and lysed by sonication (Heat 
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systems Ultrasonics model, W-385 sonicator, 1.5 s cycle, 50% duty). The resulting cell 
lysate was clarified by centrifugation at 15000 rpm for 25 min. THI4p was purified on 
Ni-NTA resin following the manufacturer’s (Qiagen) instructions. After elution, the 
protein solution was concentrated by 10 kDa MW cut-off filters (Amicon Ultra-4, 
Millipore). 
 The THI4p protein was divided into 500 µL aliquots followed by heat 
denaturation at 100 °C for 1.5 min. The mixtures were centrifuged at 4 °C for 10 min 
and the supernatant was collected followed by filtration using a 10 kDa MW cut-off 
filter (Amicon Ultra-4). The filtrate containing thiazole tautomer-ADP was stored in 
liquid nitrogen until HPLC purification.  
 The thiazole tautomer-ADP was purified by HPLC using the following gradient 
at a flow rate 2 mL/min: solvent A is water; solvent B is 100 mM NH4OAc, pH 6.6; 
solvent C is methanol. 0 min: 100% B; 5 min: 10% A, 90% B; 10 min: 25% A, 60% B, 
15% C; 13 min: 25% A, 60% B, 15% C; 17 min: 30% A, 10% B, 60% C; 18 min: 30% 
A, 10% B, 60% C; 21 min: 100% B; 30 min: 100% B. The column was Supelco LC-18-
DB (250 X 4.6 mm, 5 µm ID). The thiazole tautomer-ADP was eluted at 16 min and 
collected. The pooled solution was lyophilized and stored in liquid nitrogen to avoid the 
aromatization of the thiazole tautomer-ADP. 
 150 µL of thiazole tautomer-ADP solution was added into 350 µL buffer (50 mM 
Tris-HCl and 50 mM NaCl, pH 7.6) containing 1 U of lyophilized snake venom 
nucleotide pyrophosphatase (EC 3.6.1.9, Sigma) and MgCl2 (final concentration of 1 
mM). The mixture was incubated at 37 °C for 1h followed by filtration (10 kDa MW 
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cut-off filter) to remove the protein. The resulting filtrate contained the thiazole tautomer 
and AMP. The concentration of the thiazole tautomer in the solution was calculated by 
determining AMP concentration by HPLC analysis. 
 
Overexpression and purification of ThiSG 
 E. coli BL21(DE3) cells containing overexpression plasmid (ThiSG in pET16b 
vector) was grown in LB medium containing ampicillin with shaking at 37 °C. When 
OD600 reached about 0.6, ThiSG overexpression was induced by the addition of IPTG 
(final concentration of 0.5 mM). The cell growth was continued at 15 °C for 12 h. The 
cells were harvested by centrifugation and the resulting cell pellets were stored at -80 °C.  
 To purify ThiSG, the cell pellets were resuspended in lysis buffer (10 mM 
imidazole, 300 mM NaCl, 50 mM NaH2PO4, pH 8) and lysed by sonication (Heat 
systems Ultrasonics model, W-385 sonicator, 1.5 s cycle, 50% duty). The resulting cell 
lysate was clarified by centrifugation at 15000 rpm for 25 min. ThiSG was purified on a 
Ni-NTA resin following the manufacturer’s (Qiagen) instructions. After elution, the 
protein solution was concentrated using 10 kDa MW cut-off filters (Amicon Ultra-4, 
Millipore). Finally, the protein solution was desalted by an Econo-Pac 10DG column 
(Bio-rad) pre-equilibrated with desalting buffer (100 mM KH2PO4, 100 mM NaCl, 30% 
glycerol, pH 7.5). The protein solution was aliquoted and stored at -80 °C. 
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Trapping covalent adduct by NaBH4 
 10 µL of ThiSG (164 µM of ThiG) were incubated with two molar equivalents of 
thiazole tautomer in a final volume of 75 µL (50 mM Tris-HCl, 50 mM NaCl, pH 7.5) at 
37 °C for 20 min. The reaction was quenched by the addition of NaBH4 (0.5 mg) and 
incubated at RT for 30 min.  
 The mixture was buffer exchanged with by Amicon Ultra-0.5 three times. The 
buffer used for phosphoprotein stain analysis was 50 mM Tris-HCl, 50 mM NaCl, pH 
7.5. The buffer for intact protein mass analysis (in Dr. Russell’s Lab) was 20 mM 
NH4OAc, pH 6.6.  
 
Phosphoprotein stain analysis 
 The samples were prepared as previously described, however, to make the final 
protein concentration of every sample needed to be the same, they were loaded and 
separated on an SDS-PAGE gel. The gel was stained by Pro-Q Diamond Phosphoprotein 
Gel Stain following the manufacturer’s (Invitrogen) instructions. Finally, the gel was 
imaged using a Typhoon scanner. After imaging, the gel was also stained with 
Coomassie Blue to compare the quantity of protein in each sample. 
 
HPLC analysis of reaction reversibility 
The reaction mixtures were directly filtered using a 10 kDa MW cut-off filter 
(VWR) without the addition of NaBH4. The filtrates were analyzed by HPLC using the 
following linear gradient at a flow rate 1 mL/min over a Supelco LC-18-DB (250 X 4.6 
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mm, 5 µm ID) column: solvent A is water, solvent B is 100 mM K2HPO4, pH 6.6, 
solvent C is methanol. 0 min: 100% B; 5 min: 10% A, 90% B; 10 min: 25% A, 60% B, 
15% C; 13 min: 25% A, 60% B, 15% C; 17 min: 30% A, 10% B, 60% C; 18 min: 30% 
A, 10% B, 60% C; 21 min: 100%B. 
 
Isotopic incorporation without ThiO 
170 µL of 200 µM of thiazole tautomer was incubated with 100 µL of 220 µM of 
ThiSG in a final volume of 500 µL (50 mM Tris-HCl, 50 mM NaCl, pH 7.5) at 37 °C for 
20 min. There were a total of six reaction mixtures. After the reaction, the reaction 
mixtures were collected followed by desalting with an Econo-Pac 10DG column pre-
equilibrated with 50 mM Tris-HCl, 50 mM NaCl, pH 7.5. The desalted protein solution 
was collected and separated into seven 500 µL aliquots. Then, 80 µL of 100 mM 
15NH4Cl and glyoxylate (50 mM Tris-HCl, 50 mM NaCl, pH 7.5) were added to each. 
The reaction mixtures were incubated at 37 °C for 1 h, followed by removal of the 
proteins with a 10 kDa MW cut-off filter.  
The filtrates were analyzed by HPLC. The labeled thiazole tautomer was 
collected from 7.2 to 8 min by HPLC following the same procedure as the purification of 
the thiazole tautomer-ADP. After collection, the sample was lyophilized for 1 week. The 
degraded product, CO2-Vinyl-Thz, was isolated at 25 min and analyzed with negative-
ESI. 
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Isotopic incorporation with ThiO 
 100 µL of 220 µM ThiO was incubated with 80 µL of 100 mM 15NH4Cl and 1,2-
13C-glycine at room temperature for 1 h. At the same time, 170 µL of 200 µM thiazole 
tautomer was incubated with 100 µL of 220 µM ThiSG in final volume of 500 µL (50 
mM Tris-HCl, 50 mM NaCl, pH 7.5) at 37 °C for 20 min. There were a total of six 
reaction mixtures. After the reaction, the reaction mixtures were collected followed by 
desalting over an Econo-Pac 10DG column pre-equilibrated with 50 mM Tris-HCl, 50 
mM NaCl, pH 7.5. The desalted protein solution was collected and divided into seven 
500 µL aliquots. 
Then ThiO reaction mixtures were added to each desalted ThiSG solution and 
incubated at 37 °C for 1 h, and then filtered using a 10 kDa MW cut-off filter. The 
filtrates were analyzed by HPLC. The labeled thiazole tautomer was collected from 7.2 
to 8 min by HPLC using the same method as the purification of the thiazole tautomer-
ADP. After collection, the sample was lyophilized for 1 week. The degraded product, 
CO2-Vinyl-Thz, was isolated at 25 min and analyzed with negative ESI. 
 
 
Results and discussion 
During investigating TenI, the thiazole tautomer 2-11 was incubated with TenI 
and ThiG (The experiments were conducted by Dr. Amrita Hazra). The HPLC analysis 
showed the disappearance of 2-11, but no formation of carboxythiazole 2-12 (Figure 2-
2A and 2-2B). 
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Figure 2-2. (A) HPLC analysis of TenI assays showed TenI can convert the thiazole 
tautomer 2-11 to carboxythiazole 2-12. (B) HPLC analysis of the thiazole tautomer 2-11 
incubated with TenI and ThiG assay showed that there was no formation of 
carboxythiazole 2-12 and the thiazole tautomer 2-11 was consumed. (C) The proposed 
mechanism of the ThiG reverse reaction for the formation of 2-7 and 2-10. NaBH4 
reduces the imine of 2-7 and 2-10 to generate a possibly stable 2-16 and 2-17 for 
identification. The experiments were conducted by Dr. Amrita Hazra. 
  
 
This result led us to investigate the possibility of a ThiG reverse reaction with the 
thiazole tautomer 2-11. During thiazole biosynthesis, ThiG uses the active site lysine to 
form an imine with 2-1 15. It was proposed that during the ThiG reverse reaction the 
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active-site lysine reacts with the thiazole tautomer 2-11 followed by ring opening to 
generate 2-10 (Figure 2-2C). It could further undergo elimination of the glycine imine to 
form 2-7. To test our hypothesis, the thiazole tautomer 2-11 was incubated with ThiG to 
investigate the possibility of the reverse reaction. The thiazole tautomer 2-11 was 
reported to be generated by thiazole tautomer-ADP, which co-purified with 
Saccharomyces cerevisiae thiazole synthase, after nucleotide pyrophosphatase treatment.  
Since intermediates 2-7 and 2-10 (Figure 2-2C) have a phosphate and an imine, 
the full reaction assay (ThiSG + thiazole tautomer) was treated with NaBH4 to reduce 
the imine and form a stable intermediate. The samples were analyzed by SDS-PAGE 
with ProQ Diamond phosphoprotein stain (Invitrogen) to detect phosphorylated protein 
(Figure 2-3). After comparing with control assays, the full reaction assay gave the most 
intense ThiG signal. The full reaction without NaBH4 treatment showed a faint 
background signal. The background signal cannot be explained because the company 
refused to reveal the ingredients. But the results suggested the presence of phosphate and 
imine on ThiG after the reaction. Furthermore, there was no ThiG signal difference in all 
of assays when the active-site lysine was mutated. Lastly, thiazole tautomer-ADP 
containing the thiazole tautomer moiety was tested with ThiSG. The phosphoprotein 
stain analysis suggested that ThiG did not react with it. These results implied that ThiG 
reacts with the thiazole tautomer 2-11 to form an intermediate with the phosphate and 
imine group. 
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Figure 2-3. ThiSG and ThiG K96A reactions analyzed by SDS-PAGE with 
phosphoprotein stain (Left) and Coomassie Blue (Right). The MW difference of ThiG in 
ThiSG (in pET16b) and ThiG K96A (in pET28b) were due to different His-tag 
sequences. 
 
 
 In order to characterize the intermediate, the full reaction sample after NaBH4 
treatment was analyzed by mass spectrometry. After comparing with the control sample, 
the molecular weight (MW) of ThiG in the full reaction assay increased by 196 Da. 
Based on the proposed reverse reaction (Figure 2-2C), +196 Da corresponds to 2-17, 
which is derived from 2-7 after NaBH4 reduction (Figure 2-4A). Furthermore, the full 
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reaction assay was carried out with ThiG K96A following the same procedure. ThiG 
K96A did not show a MW shift (Figure 2-4B). The results tallied with phosphoprotein 
stain analysis and suggest that the active site lysine reacts with the thiazole tautomer to 
undergo the reverse reaction. 
 
 
Figure 2-4. The MW measurement of ThiSG and ThiG K96A after NaBH4 treatment. 
(A) ThiG increased by 196 Da in the full reaction assay. (B) ThiG K96A was not 
modified in the full reaction assay. The MW difference of ThiG in ThiSG (in pET16b) 
and ThiG K96A (in pET28b) were because of different His-tag sequences. 
 
 
 In the proposed thiazole biosynthesis (Figure 2-1), intermediate 2-7 reacts with 
the glycine imine 2-9 generated by ThiO-catalyzed glycine oxidation to generate the 
thiazole tautomer 2-11. In our previous studies, we have shown successful reconstitution 
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using ThiG, ThiS, NifS, ThiF, and ThiO. But the identification of intermediate 2-7 could 
allow us to investigate the later steps of thiazole biosynthesis involving ThiO and ThiG 
only. Therefore, the competence of intermediate 2-7 in this biosynthesis was investigated 
to observe the regeneration of the thiazole tautomer 2-11 after the addition of glycine 
imine 2-9. Therefore, intermediate 2-7 was generated by the reverse reaction followed 
by desalting to remove excess thiazole tautomer 2-11. The resulting solution containing 
intermediate 2-7 was incubated with glycine imine 2-9 generated by glyoxylate and 
ammonium chloride. Finally, NaBH4 was added to quench the reaction and observe the 
regeneration of unmodified ThiG by mass spectrometry (Figure 2-5A). In addition, the 
assays without NaBH4 treatment were analyzed by HPLC to monitor the quantity of the 
thiazole tautomer 2-11 (Figure 2-5B). In the reverse reaction assay, ThiSG was 
incubated with two molar equivalents of the thiazole tautomer 2-11. The quantity of 2-11 
decreased after the reaction. The addition of glycine imine 2-9 into the reverse reaction 
assay showed the regeneration of the thiazole tautomer 2-11. These results suggested 
that the intermediate 2-7 could react with the glycine imine 2-9 to regenerate the thiazole 
tautomer 2-11 and demonstrated the competency of the intermediate 2-7.  
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Figure 2-5. (A) The overlapping [M+21H]21+ spectra of the reverse (blue) and forward 
(pink) reactions suggested that the addition of glycine imine 2-9 in the forward reaction 
to the intermediate 2-7 from the reverse reaction regenerated unmodified ThiG. (B) The 
HPLC analysis of the ThiG assays showed that the regeneration of the thiazole tautomer 
2-11 in the reverse reaction with the addition of the glycine imine 2-9 compared with the 
reverse reaction. 
  
 
To investigate the identity of the intermediate 2-7, different isotope-labeled 
glycine imines 2-9 were used to generate the isotope-labeled thiazole tautomer 2-11. 
However, the thiazole tautomer 2-11 was prone to degradation, so the thiazole tautomer 
2-11 was lyophilized to degrade as carboxylvinylthiazole 2-18 for MS analysis (Figure 
2-6). First, 15NH4Cl was incubated with glyoxylate to generate 15N-glycine imine. 15N-
glycine imine was added into the solution of intermediate 7. The MW of 
carboxylvinylthiazole 2-18 had +1 Da (Figure 2-6B). Furthermore, 1,2-13C-glycine 
imine could be generated via the oxidation of 1,2-13C-glycine catalyzed by ThiO. In this 
experiment, carboxylvinylthiazole 2-18 had +2 Da (Figure 2-6C). These experiments 
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demonstrated the competency of the intermediate 2-7 and the reconstitution of the later 
steps of thiazole biosynthesis involving ThiG and ThiO. Lastly, the possible substrate 
channel between ThiG and ThiO was studied by adding an excess of 15NH4Cl to the 
ThiO-catalyzed 1,2-13C-glycine oxidation reaction. The result showed +2 and +3 Da 
indicating that 15NH4Cl reacted with 13C-glycine imine to generate 13C,15N-glycine imine 
(Figure 2-6D). This suggested that there is no compact channel between ThiO and ThiG. 
 
 
Figure 2-6. Mass spectra of carboxylvinylthiazole 2-18 suggesting isotope 
incorporation. (A) Carboxylvinylthiazole standard; (B) 15N-glycine imine generated by 
15NH4Cl and glyoxylate; (C) 1,2-13C-glycine imine generated by oxidation of 1,2-13C-
glycine catalyzed by ThiO; (D) 15NH4Cl and 1,2-13C-glycine with ThiO. 
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Conclusion 
This chapter has demonstrated that the intermediate 2-7 in thiazole biosynthesis 
was generated by the reverse reaction. Moreover, the intermediate 2-7 was used to 
investigate thiazole biosynthesis involving ThiG and ThiO in the later steps. 
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CHAPTER III 
THIAMIN PYRIMIDINE BIOSYNTHESIS IN CANDIDA ALBICANS: 
A REMARKABLE REACTION BETWEEN HISTIDINE AND PYRIDOXAL 
PHOSPHATE*  
 
Introduction 
In Saccharomyces cerevisiae, thiamin is biosynthesized from thiazole (3-8) and 
pyrimidine (3-9) moieties. Thiazole 3-8 has been investigated to show that the thiazole 
synthase (THI4p) uses an active-site cysteine, glycine and nicotinamide adenine 
dinucleotide (NAD) to make thiazole moiety 16. 
The past feeding experiments implied 4-amino-2-methyl-5-
hydoxymethylpyrimidine phosphate (HMP-P, 3-7) is formed from histidine (3-4) and 
pyridoxal 5’-phosphate (PLP, 3-5) 11,17-19. Furthermore, genetic studies have 
demonstrated that HMP-P formation requires only a single gene (THI5) 9. Based on all 
information, HMP-P is formed using remarkable chemistry without any chemical or 
biochemical precedent. In this chapter, the overexpression of THI5p, the reconstitution 
of the enzyme activity, and preliminary characterization of the reaction are reported. 
These experiments suggest that the THI5 protein is the histidine source for HMP-P 
formation and that THI5p is a single turnover protein.  
 
                                                
*Reprinted with permission from “Thiamin Pyrimidine Biosynthesis in Candida albicans: A 
Remarkable Reaction between Histidine and Pyridoxal Phosphate” by Lai, R.-Y.; Huang, S.; 
Fenwick, M. K.; Hazra, A.; Zhang, Y.; Rajashankar, K.; Philmus, B.; Kinsland, C.; Sanders, J. 
M.; Ealick, S. E.; Begley, T. P., 2012. Journal of the American Chemical Society, 134, 9157-
9159, Copyright [2012] by American Chemical Society. 
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Scheme 3-1. Thiamin pyrophosphate biosynthesis in S. cerevisiae 20. 
 
 
Experimental methods 
Source of chemicals  
All chemicals were purchased from Sigma-Aldrich Corporation (U.S.A.) unless 
otherwise mentioned. Trypsin was obtained from Promega. M9 salts were obtained from 
Becton Dickinson. Kanamycin and IPTG were purchased from LabScientific Inc. 
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Analytical HPLC (Agilent 1260 instrument) was carried out using a Supelcosil LC-18 
column (250 mm X 10 mm, 5 µm ID). LC-MS (Agilent 1260 instrument and Bruker 
microTOF-Q II) was carried out using a Supelcosil LC-18-T column (150 mm X 3 mm, 
3 µm ID). The solvents for HPLC and LC-MS were HPLC grade and LC-MS grade 
respectively and were obtained from EMD. Sequencing grade trypsin was obtained from 
Promega. Slide-A-Lyzer Dialysis Cassettes, 10K MWCO were purchased from Thermo 
Scientific. 
 
THI5p overexpression and purification  
E. coli BL21(DE3) cells containing the THI5 gene in pET28b was grown in 
minimal medium (11.3 g M9 salts, 13.3 mL 50% glucose, 2.7 mL 1 M MgSO4, 100 µL 1 
M CaCl2 diluted to 1 L medium) containing kanamycin (40 µg/mL) with shaking at 37 
°C until the OD600 reached 0.6. At this point, protein overexpression was induced with 
IPTG (final concentration, 500 µM), and cell growth was continued at 15 °C for 16 h. 
The cells were harvested by centrifugation, and the cell pellets from 1 L of culture were 
resuspended in 20 mL of lysis buffer (10 mM imidazole, 300 mM NaCl, 50 mM 
NaH2PO4, 5 mM DTT, pH 8.0) and lysed by sonication (Heat System Ultrasonics model 
W-385 sonicator, 1.5 s cycle, 60% duty). The resulting cell lysate was clarified by 
centrifugation and the THI5 protein was purified on a Ni-NTA column following the 
manufacturer’s instructions. After elution, the protein was desalted under anaerobic 
conditions using a 10DG column (BioRad) pre-equilibrated with 100 mM Tris-HCl 
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buffer, 5 mM DTT, 30% glycerol, pH 7.5. The purified protein was stored in aliquots in 
liquid nitrogen. The purity was analyzed by SDS PAGE and ESI-MS (Figure 3-1). 
 
 
Figure 3-1. Analysis of purified THI5p. A) SDS PAGE analysis. B) ESI-MS analysis 20. 
 
 
Reconstitution of the THI5p activity  
100 µL of 600 µM THI5p was anaerobically pre-incubated with 1.5 equivalent of 
Fe(NH4)2(SO4)2 in an ice bath for 30 min. The mixture was anaerobically desalted using 
a Bio-Spin 6 column (Bio-Rad) pre-equilibrated with 100 mM Tris-HCl, 5 mM DTT, pH 
7.5. Subsequently, 2 molar equivalents of PLP were added. The reaction mixture was 
aerobically incubated at room temperature for 3 h, filtered using a 10 kDa MW cut-off 
filter, and analyzed by HPLC and LC-MS.  
 
HPLC conditions for analyzing the THI5p reaction mixture 
The following linear gradient, at a flow rate of 2 mL/min, on a Supelcosil LC-18 
column (250 mm X 10 mm, 5 µm ID) was used: solvent A is water, solvent B is 100 
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mM KPi, pH 6.6, solvent C is methanol; 0 min: 100% B; 5 min: 10% A, 90% B; 10 min: 
25% A, 60% B, 15% C; 13 min: 25% A, 60% B, 15% C; 17 min: 30% A, 10% B, 60% 
C; 18 min: 30% A, 10% B, 60% C; 21 min: 100% B. 
 
15N-THI5p overexpression and purification 
The overexpression and purification procedures were the same as described 
above for THI5p except 14NH4Cl was replaced by 15NH4Cl (Cambridge Isotope 
Laboratories, Inc.) in the M9 salts. Analysis of the labeled and unlabeled proteins by 
ESI-MS confirmed a high level of 15N incorporation in the 15N-THI5p (Figure 3-2). 
 
 
Figure 3-2. The ESI-MS analysis of 14N-THI5p and 15N-THI5p 20. 
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LC-MS analysis of  the THI5p reaction mixture  
The following linear gradient, at a flow rate of 0.4 mL/min, on a Supelcosil LC-
18-T column (150 mm X 3 mm, 3 µm ID) was used: solvent A is 20 mM NH4OAc, pH 
6.6, solvent B is 75% methanol; 0 min: 100% A; 3 min: 100% A; 8 min: 50% A, 50% B; 
10 min: 100% A. The HPLC is coupled with a microTOF-Q II for MS analysis in the 
positive mode. 
 
Trypsin digestion of inactive THI5p  
After completion of HMP-P formation, the inactive THI5p (50 µg, 1.8 µL of 660 
µM THI5p) was added to 10 µL of 6 M guanidine-HCl, 25 mM ammonium bicarbonate, 
pH 8.0. 1 µL of 200 mM DTT in 25 mM ammonium bicarbonate, pH 8.0, was then 
added to the denatured protein solution and the resulting mixture was incubated at room 
temperature for 1 hour. After that, 10 µL of 200 mM iodoacetamide in 25 mM 
ammonium bicarbonate pH 8.0, were added and the reaction mixture was incubated at 
room temperature in the dark for 1 hour. Finally, 77.5 µL of 25 mM ammonium 
bicarbonate, pH 8.0, were added to reduce the guanidine-HCl concentration to 0.6 M 
followed by the addition of 1 µg of trypsin. The mixture was incubated at 37 °C 
overnight and stored at -20 °C until analysis. 
 
LC-MS conditions for analyzing THI5p samples after trypsin digestion  
The following linear gradient, at a flow rate of 0.4 mL/min, on a Supelcosil LC-
18-T column (150 mm X 3 mm, 3 µm ID) was used: solvent A is 0.1% formic acid in 
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water, solvent B is 0.1% formic acid in acetonitrile; 0 min: 95% A, 5% B; 1 min: 100% 
A; 60 min: 35% A, 65% B. The HPLC is coupled with a microTOF-Q II for MS analysis 
in the positive mode. 
 
 
Figure 3-3. LC-MS analysis (extracted ion chromatograms) of the histidine-containing 
tryptic peptides derived from active and inactive THI5p 20. Blue trace: peptides derived 
by trypsinolysis from the THI5p+Fe(III)+PLP reaction mixture. Green trace: peptides 
derived by trypsinolysis from the THI5p+Fe(III) control. All expected histidine 
containing peptides were detected except for His66.  
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THI5p refolding experiments  
1 mL of 700 µM THI5p was added to 25 mL of denaturing buffer (50 mM 
KH2PO4, 300 mM NaCl, 5 mM mercaptoethanol, 8 M urea, pH 7.8) and incubated at 
room temperature for 1 hour. The solution was then transferred to a Slide-A-Lyzer 
Dialysis Cassette, 10K MWCO (Thermo Scientific) and dialyzed against 2 L of dialysis 
buffer (50 mM KH2PO4, 300 mM NaCl, 5 mM mercaptoethanol, 5 M urea, pH 7.8) for 5 
h. Subsequently, the cassette was transferred to the next buffer (50 mM KH2PO4, 300 
mM NaCl, 5 mM mercaptoethanol, 2 M urea, pH 7.8) and dialyzed overnight. The 
protein solution was then loaded into a 5 mL Ni-NTA column pre-equilibrated with 50 
mM KH2PO4, 300 mM NaCl, 5 mM mercaptoethanol, 2 M urea, pH 7.8. The Ni-NTA 
column was installed on an FPLC and eluted, at a flow rate of 1 mL/min, with the 
following linear gradient: solvent A is 50 mM KH2PO4, 300 mM NaCl, 5 mM 
mercaptoethanol, 2 M urea, pH 7.8; solvent B is 50 mM KH2PO4, 300 mM NaCl, 5 mM 
mercaptoethanol, pH 7.8; 0 min: 100% A; 120 min: 100% B. Finally, the refolding 
protein was eluted by 200 mM imidazole, 50 mM KH2PO4, 300 mM NaCl, 5 mM 
mercaptoethanol, pH 7.8. After concentration, the protein solution was buffer-exchanged 
using a Bio-Spin 6 Column (Bio-Rad) into 100 mM Tris-HCl, 5 mM DTT, pH 7.5. The 
activity of the refolded THI5p protein was determined as described above for the native 
protein.  
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Mutagenesis of THI5p  
The mutants shown in Table 3-1 were constructed. The activity of each mutant was 
determined as described above for the native protein. Most of the H18A mutant 
overexpressed as inclusion bodies, however a very small amount of this mutant could be 
purified from the crude lysate and was found to be active.  
 
Table 3-1. THI5p histidine mutants and their activities 20 
 
 
 
Results and discussion 
Reconstitution of protein activity 
 Candida albicans THI5p was heterologously overexpressed in E. coli BL21 
(DE3) cells grown in minimal media. The protein was purified by Ni-NTA 
chromatography. Finally the protein was buffer-exchanged anaerobically and stored in 
liquid nitrogen until the further studies.  
H18N
H66N
H128N
H234N
H273N
H323N
H18D
H18A
H66G
Inclusion body
Active
Active
Active
Active
Inactive
Inclusion body
Inclusion body
Inactive
Mutant Mutant
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 The active THI5p was incubated with Fe(II) or Fe(III) anaerobically followed by 
removal of excess iron. Addition of PLP to the protein solution under aerobic condition 
generated HMP-P. The product was characterized by NMR and ESI-MS spectrometry. 
  The HPLC analysis showed the reaction was metal dependent (Figure 3-4). In 
the presence of EDTA, the production of HMP-P was abolished. It also required aerobic 
condition to generate HMP-P. Moreover, the addition of histidine did not affect the 
amount of HMP-P production.  
 
 
Figure 3-4. Reconstitution of the THI5-catalyzed reaction 20. (A) The reconstitution 
reaction requires PLP and Fe(III) but is independent of added histidine. The small 
amount of HMP-P shown in the green trace is due to product that co-purifies with THI5 
and not to synthesis. (B) The reaction to form HMP-P requires oxygen. 
 
 
This result seemed not tally with the past feeding experiments. Hence, we 
hypothesized that one of histidine residues could be the N=C-N donor for HMP-P 
formation. In order to test this hypothesis, 15N-THI5p was prepared by growing 
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overexpression strain in 15NH4Cl-contiaining minimal medium. 15N-THI5p was used to 
set up the assays analyzed by LC-MS (Figure 3-5). The molecular weight of HMP-P 
showed the expected [M+2] peak corresponding to incorporation of two 15N-atoms from 
protein. This suggested that THI5p serves as the donor of the histidine-derived atoms of 
HMP-P.  
 
 
Figure 3-5. MS analysis of HMP-P formed using (A) 14N-THI5p and (B) 15N-THI5p 20. 
 
 
THI5p refolding experiment 
 Although 15N-THI5p assays gave an intriguing result for possibility of THI5p 
histidine residue as the substrate, it could be a co-purified metabolite served as the 
substrate. In order to eliminate this concern, THI5p was denatured in 8 M urea solution 
followed by slow dialysis to 2 M urea solution. Then the THI5p solution was loaded into 
Ni-NTA column. The denatured THI5p could be refolded by gradually decreasing urea 
concentration by FPLC. Finally, THI5p could be eluted and concentrated to test its 
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activity. The refolding THI5p still showed about 59% of the specific activity of the 
original preparation (Figure 3-6). 
  
 
Figure 3-6. THI5p denatured in urea and refolded is active 20. Red trace: HMP-P 
produced by THI5p before urea denaturation. Blue trace: HMP-P produced by THI5p 
after denaturation in 8 M urea and renaturation by slow dialysis. 
 
 
 Since denaturation destroys the active-site structure and dialysis removes any 
released metabolite, this experiment provides strong support for the hypothesis that the 
histidine-derived N=C−N fragment is extracted from the THI5 protein. 
 
Trypsin digestion of inactive THI5p and mutagenesis of THI5p 
 All of preliminary results indicated that THI5p serves as N=C-N donor for HMP-
P biosynthesis. But we do not know which residue as the substrate. Since the past 
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feeding experiments suggested histidine as the substrate, there are six histidine residues 
in THI5p as the candidates to test.  
 Hence the inactive THI5p after full reaction assay was digested by trypsin 
followed by LC-MS analysis. The extracted ion chromatography (EIC) was used to see 
the disappearance of the peptides containing each histidine (Figure 3-3). Five of six 
peptides could be found but without disappearance compared with apo-THI5p digestion 
sample. Unfortunately the peptide containing His66 cannot be identified in both of 
samples.  
 In order to get more information, all of histidine mutants were overexpressed and 
test their activities. His18 mutants formed the inclusion body, but fortunately H18A 
could be purified as a very tiny amount. H18A was active to generate HMP-P. In other 
five histidine mutants, only His66 was inactive to generate HMP-P after mutation.  
 With these two experiments, they implied that His66 might be the N=C-N donor 
to form HMP-P. 
 
Active site of THI5p crystal structure 
This work was done by Dr. Siyu Huang and Michael K. Fenwick at Dr. Steve E. 
Ealick lab at Cornell University. The active site of THI5p showed PLP forms imine with 
Lys62 and His66 is closed to PLP (Figure 3-7).  
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Figure 3-7. Active site of C. albicans THI5p showing PLP bound via an imine to Lys62 
and His66 in close proximity to the PLP 20. This was done by Dr. Siyu Huang. 
 
 
 The crystal structure was complementary with the results of mutagenesis of 
THI5p. Based on all of results, His66 is the N=C-N donor for HMP-P synthesis. 
 
 
Conclusion 
 C. albicans THI5p can be readily overexpressed in E. coli. Furthermore the 
protein uses PLP and the active-site His66 to form HMP-P. The reaction also requires 
oxygen and iron. 
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CHAPTER IV 
CHARACTERIZATION OF THE MODIFIED HIS66 AND PLP BY-PRODUCTS 
 
Introduction 
 In Saccharomyces cerevisiae thiamin biosynthesis (Scheme 3-1), the thiazole 
synthase (THI4p) and the pyrimidine synthase (THI5p) have been investigated as single 
turnover proteins 16,20. In thiazole biosynthesis, THI4p uses an active-site cysteine to 
react with glycine and nicotinamide adenine dinucleotide (NAD) to generate the thiazole 
moiety. In pyrimidine biosynthesis, His66 4-1 in the THI5p active-site reacts with 
pyridoxal 5’-phosphate 4-2 (PLP) via an imine bound with Lys62 to form 4-amino-2-
methyl-5-hydoxymethylpyrimidine phosphate 4-3 (HMP-P). The reaction requires both 
oxygen and iron. This biosynthesis involves remarkable chemistry without any 
precedent. To study the reaction mechanism, the characterization of His66 in inactive 
THI5p (after HMP-P formation) is necessary, as well as identification of the by-product 
of PLP 4-2. In this chapter, the chemical equation of HMP-P 4-3 formation is solved for 
further mechanistic investigations.  
 
 
Figure 4-1. The result of the THI5p reconstitution in chapter 3. 
 
N
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Experimental methods 
Source of chemicals  
All chemicals were purchased from Sigma-Aldrich (U.S.A.) unless otherwise 
noted. M9 salts were obtained from Becton Dickinson. Kanamycin and IPTG were 
purchased from LabScientific Inc. Analytical HPLC (Agilent 1260 instrument) was 
carried out using a Supelcosil LC-18 column (250 mm X 10 mm, 5 µm ID). LC-MS 
(Agilent 1260 instrument and Bruker microTOF-Q II) was carried out using a Supelcosil 
LC-18-T column (150 mm X 3 mm, 3 µm ID) and Synergi Polar-RP 100A column (50 
mm X 2 mm, 2.5 µm). The solvents for HPLC and LC-MS were HPLC grade and LC-
MS grade respectively and were obtained from EMD. Sequencing grade trypsin was 
obtained from Promega. 
 
THI5p overexpression and purification  
E. coli BL21(DE3) cells containing the THI5 gene in pET28b vector was grown 
in minimal media (11.3 g M9 salts, 13.3 mL 50% glucose, 2.7 mL 1 M MgSO4, 100 µL 
1 M CaCl2 diluted to 1 L medium) containing kanamycin (40 µg/mL) with shaking at 37 
°C until the OD600 reached 0.6. Protein overexpression was then induced with IPTG 
(final concentration of 500 µM), and cell growth was continued at 15 °C for 16 h. The 
cells were harvested by centrifugation, and the cell pellets from 1 L of culture were 
resuspended in 20 mL of lysis buffer (10 mM imidazole, 300 mM NaCl, 50 mM 
NaH2PO4, 5 mM DTT, pH 8.0) and lysed by sonication (Heat System Ultrasonics model 
W-385 sonicator, 1.5 s cycle, 60% duty). The resulting cell lysate was clarified by 
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centrifugation and the THI5 protein was purified on a Ni-NTA column following the 
manufacturer’s instructions. After elution, the protein was desalted under anaerobic 
conditions using an Econo-Pac 10DG column (BioRad) pre-equilibrated with 100 mM 
Tris-HCl buffer, 5 mM DTT, 30% glycerol, pH 7.5. The purified protein was stored in 
aliquots in liquid nitrogen. 
 
Reconstitution of the THI5p activity  
100 µL of 600 µM THI5p was anaerobically pre-incubated with 1.5 molar 
equivalent of Fe(NH4)2(SO4)2 in an ice bath for 30 min. The mixture was anaerobically 
desalted using a Bio-Spin 6 column (Bio-Rad) pre-equilibrated with 100 mM Tris-HCl, 
5 mM DTT, pH 7.5. Subsequently, 2 equivalents of PLP were added. The reaction 
mixture was aerobically incubated at room temperature for 3 h, filtered using a 10 kDa 
MW cut-off filter, and analyzed by HPLC and LC-MS. 
 
HPLC conditions for analyzing the THI5p reaction mixture  
The following linear gradient, at a flow rate of 2 mL/min, on a Supelcosil LC-18 
column (250 mm X 10 mm, 5 µm ID) was used: solvent A is water, solvent B is 100 
mM KH2PO4, pH 6.6, solvent C is methanol; 0 min: 100% B; 5 min: 10% A, 90% B; 10 
min: 25% A, 60% B, 15% C; 13 min: 25% A, 60% B, 15% C; 17 min: 30% A, 10% B, 
60% C; 18 min: 30% A, 10% B, 60% C; 21 min: 100%B. 
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15N-THI5p overexpression and purification  
The overexpression and purification procedures were the same as described 
above for THI5p except 14NH4Cl was replaced with 15NH4Cl (Cambridge Isotope 
Laboratories, Inc.) in the M9 salts. 
 
Trypsin digestion of inactive THI5p  
After completion of HMP-P formation, the mixture was desalted using a Bio-
Spin 6 column (Bio-Rad) pre-equilibrated with 25 mM ammonium bicarbonate, pH 8.0. 
The inactive THI5p (50 µg, 1.8 µL of 660 µM THI5p) was added to 10 µL of 6 M 
guanidine-HCl, 25 mM ammonium bicarbonate, pH 8. 1 µL of 200 mM DTT in 25 mM 
ammonium bicarbonate pH 8.0, were then added to the denatured protein solution and 
the resulting mixture was incubated at room temperature for 1 hour. After incubation, 10 
µL of 200 mM iodoacetamide in 25 mM ammonium bicarbonate pH 8.0, were added and 
the reaction mixture was incubated at room temperature in dark for 1 hour. Finally, 77.5 
µL of 25 mM ammonium bicarbonate pH 8.0, were added to reduce the guanidine-HCl 
concentration to 0.6 M followed by the addition of 1 µg of trypsin. The mixture was 
incubated at 37 °C overnight and stored at -20 °C until analysis. 
 
LC-MS conditions for analyzing THI5p samples after trypsin digestion  
The following linear gradient was used at a flow rate of 0.4 mL/min over a 
Synergi Polar-RP 100A column (50 mm X 2 mm, 2.5 µm): solvent A is 0.1% formic 
acid in water, solvent B is 0.1% formic acid in acetonitrile; 0 min: 100% A; 1 min: 100% 
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A; 8 min: 88% A, 12% B; 31 min: 65% A, 35%B; 46 min: 35% A, 65% B; 48 min: 
100% B; 53 min: 100%B; 56 min: 100%A; 65 min: 100% A. The HPLC is coupled with 
a microTOF-Q II for MS analysis in the positive mode. 
 
The modified peptide tagged by aminooxy-biotin  
The full reaction sample was dialyzed overnight against 10 mM HEPES, 5 M 
urea, pH 7.4. 50 µM of 1 mL of the sample was added with 100 µL of 30 mM 
aminooxy-biotin (Dojindo Lab) in water and 20 µL of 1.8 M NaOAc, pH 4.7. The 
mixture was incubated at room temperature for 24 h. 200 µg of the protein sample was 
digested with trypsin. After the digestion, the modified peptide with the aminooxy-biotin 
tag was purified by avidin resin. The purified peptide was eluted by the incubation of the 
avidin resin at 100 °C for 20 min. Finally, the sample was analyzed by LC-MS.  
 
The modified peptide tagged by biotin hydrazide  
The full reaction sample with 50 µg of protein was digested with trypsin. The 
mixture was added to an equal volume of 40 mM of biotin hydrazide in DMSO. The 
mixture was incubated at RT for 24 h and then dried by speedvac. The sample was then 
resuspended in 200 µL of water. Finally, the sample was analyzed by LC-MS. 
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The modified peptide tagged by methoxyamine 
50 µg of protein from the full reaction sample were digested with trypsin. The 
mixture was added to an equal volume of 100 mM of methoxyamine in 0.2 M NaOAc, 
pH 5.4, and incubated at 37 °C for 24 h. Finally, the mixture was analyzed by LC-MS. 
 
Synthesis of 4-6 
 
2 g of Fmoc-Asp-OBz 4-4 (Bachem) and 1.35 g of 
(cyanomethylene)phosphorane 4-5 were added in 100 mL of CH2Cl2 under an argon 
atmosphere. The mixture was placed in an ice bath followed by the addition of 0.95 g of 
N-(3-Dimethylaminopropyl)-N’-ethylcarbodiimide hydrochloride (EDCI) and 5.5 mg of 
4-(Dimethylamino)pyridine (DMAP). Finally, the mixture was stirred at room 
temperature overnight. The solvent was removed after the reaction. The product was 
purified by silica gel (CH2Cl2/Ethyl acetate = 25/2). Finally, the product 4-6 is white 
solid with 75% yield (2.45 g). 1H-NMR (300 MHz, CDCl3): δ 7.75 (d, 2H, J = 7.5 Hz, 
ArH), 7.67~7.23 (26H, ArH), 6.09 (d, 1H, J = 9 Hz, -NH-), 5.13 (dd, 2H, J = 12.6, 19.8 
Hz, -CH2-), 4.83-4.64 (m, 1H, -CH-), 4.51-4.37 (m, 1H, -CH-), 4.32-4.13 (m, 2H, -CH2-
), 3.66 (dd, 1H, J = 5.1, 16.8 Hz, -CHH-), 3.15 (dd, 1H, J = 4.2, 17.1 Hz, -CHH-). 13C-
NMR (75 MHz, CDCl3): δ 193.3, 171.6, 156.2, 144.1, 143.8, 141.2, 133.6, 133.5, 133.3, 
129.3, 128.5, 127.7, 127.6, 127.1, 125.3, 125.2, 123.2, 121.9, 119.9, 67.1, 66.9, 47.2, 
40.8, 40.7. Observed [M+H]+ = 729.2540 (Calculated [M+H]+ = 729.2513).   
BnO
O
NH O
Fmoc
CN
PPh3
4-6
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Synthesis of 4-7  
 
2.45 g of 4-6 was dissolved in 100 mL of CH2Cl2/MeOH (7:3) under an argon 
atmosphere. The solution was brought to -78 °C followed by the purge of ozone. The 
reaction was stopped until the color of solution turned blue. Then the solution was 
purged with nitrogen to remove excess ozone in the solution at -78 oC. After the color of 
the solution disappeared, the solvent was removed. The product was purified by silica 
gel (CH2Cl2). Finally, the product 4-7 is white solid with 90% yield (1.48 g). 1H-NMR 
(300 MHz, CDCl3): δ 7.75 (d, 2H, J = 7.5 Hz, ArH), 7.56 (d, 2H, J = 7.5 Hz, ArH), 7.43-
7.27 (m, 9H, ArH), 5.74 (d, 1H, J = 7.8 Hz, -NH-), 5.18 (dd, 2H, J = 12, 18.6 Hz, -CH2-
), 4.81-4.75 (m, 1H, -CH-), 4.44-4.31 (m, 2H, -CH2-), 4.20 (t, 1H, J = 6.9 Hz, -CH-), 
3.86 (s, 3H, -OMe), 3.51-3.47 (m, 2H, -CH2-). 13C-NMR (75 MHz, CDCl3): δ 191.2, 
170.1, 160.2, 155.8, 143.7, 143.6, 141.3, 134.8, 128.6, 128.5, 128.3, 127.7, 127.1, 125.1, 
120.0, 67.8, 67.3, 53.2, 49.8, 47.0, 41.8. Observed [M+Li]+ = 494.1770 (Calculated 
[M+Li]+ = 494.1791). 
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Synthesis of 4-8 
 
1.48 g of 4-7 was dissolved in 40 mL of MeOH. Then 100 mg of 30% Pd/C was 
added into the solution. The reaction was performed under 1 atm of H2 for 1 hour. After 
the reaction, Pd/C was filtered off by celite. Finally, the filtrate was dried and the 
product 4-8 was purified by silica gel. It is white solid with 85% yield (1.02 g). 1H-NMR 
(300 MHz, CDCl3): δ 7.74 (d, 2H, J = 7.5 Hz, ArH), 7.57 (d, 2H, J = 7.2 Hz ArH), 7.41-
7.26 (m, 4H, ArH), 6.01-5.77 (br, 1H, -NH-), 4.81-4.73 (m, 1H, -CH-), 4.46-4.34 (m, 
2H, -CH2-), 4.20 (t, 1H, J = 6.9 Hz -CH-), 3.85 (s, 3H, -OMe), 3.67-3.19 (br, 2H, -CH2-). 
13C-NMR (75 MHz, CDCl3): δ 164.9, 156.1, 143.5, 141.2, 127.7, 127.1, 125.0, 120.0, 
67.5, 46.9, 29.7. Observed [M-H]- = 396.1066 (Calculated [M-H]- = 396.1083). 
 
Synthesis of 4-9 
 
1.02 g of 4-8 and 0.32 g of methoxylamine hydrochloride were added in 20 mL 
of MeOH. The mixture was stirred at room temperature for 2 h. After the reaction, the 
solvent was removed. The solids were dissolved in CH2Cl2 followed by extraction with 
water three times. Finally, the CH2Cl2 portion was collected and dried by anhydrous 
sodium sulfate. After filtration and removing the solvent, the resulting product 4-9 was a 
HO
O
NH O
Fmoc
OMe
O
4-8
HO
O
NH N
Fmoc
OMe
O
OMe 4-9
HO
O
NH N
Fmoc
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O
MeO
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white solid (1.0 g, 95% yield). 1H-NMR (300 MHz, CDCl3): δ 7.76 (d, 2H, J = 7.5 Hz, 
ArH), 7.57 (m, 2H, ArH), 7.40 (m, 2H, ArH), 7.34-7.26 (m, 2H, ArH), 5.63 (t, 1H, J = 
8.7 Hz, -NH-), 4.69 (m, 1H, -CH-), 4.42-4.30 (m, 2H, -CH2-), 4.22 (t, 1H, J = 6.9 Hz, -
CH-), 4.08 (s, 3H, -OMe), 3.86 (s, 3H, -OMe), 3.75 (s, 3H, -OMe), 3.17-3.01 (m, 2H, -
CH2-). 13C-NMR (75 MHz, CDCl3): δ 174.6, 171.6, 164.0, 163.9, 156.0, 155.7, 147.1, 
147.6, 143.8, 143.7, 143.6, 143.5, 141.2, 127.7, 127.0, 125.1, 125.0, 67.3, 67.2, 53.1, 
53.0, 52.6, 51.2, 51.1, 47.0, 46.9, 29.7, 28.0, 27.6. Observed [M-H]- = 425.1328 
(Calculated [M-H]- = 425.1349). 
 
Solid phase peptide synthesis  
The procedure followed the standard protocol. However, DMSO was added to a 
20% final concentration in the amide coupling step from the installation of the modified 
residue 4-9. Every amide coupling step was performed three times. After TFA cleavage, 
the peptide was dissolved in water and then analyzed by LC-MS. The data was analyzed 
by EIC and showed the desired peptide with methyl ester 4-10. The peptide 4-10 
solution was mixed with the same volume of 0.2 M LiOH in water. The mixture was 
incubated at room temperature for 1 h followed by LC-MS analysis. The result showed 
the desired peptide 4-11. 
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PLP by-product trapped by phenylhydrazine 
After the reaction finished, the mixture was filtered using a 10 kDa cut-off filter. 
10 µL of phenylhydrazine stock solution (5 µL in 1 mL of water) was added to the 
filtrate. The mixture was incubated at 37 °C for 2.5 h followed by HPLC analysis. 
 
HPLC conditions for analyzing the phenylhydrazine derivatizing reaction 
The following linear gradient, at a flow rate of 2 mL/min, on a Supelcosil LC-18 
column (250 mm X 10 mm, 5 µm ID) was used: solvent A is water, solvent B is 100 
mM KH2PO4, pH 6.6, solvent C is methanol; 0 min: 100% B; 4 min: 25% A, 60% B, 
15% C; 8 min: 20% A, 40% B, 40% C; 14 min: 10% A, 10% B, 80% C; 18 min: 10% A, 
10% B, 80% C; 20 min: 25% A, 50% B, 25% C; 22 min: 100%B; 30 min: 100% B.  
 
HPLC conditions for collecting the phenylhydrazine derivatizing reaction 
The condition is identical to the previous one. But solvent B is 100 mM 
NH4OAc, pH 6.6. 
 
LC-MS conditions 
The following linear gradient, at a flow rate of 0.4 mL/min, on a Supelcosil LC-
18-T column (150 mm X 3 mm, 3 µm ID) was used: solvent A is 20 mM NH4OAc, pH 
6.6, solvent B is 75% methanol; 0 min: 100% A; 3 min: 100% A; 8 min: 50% A, 50% B; 
10 min: 100% A. The HPLC was coupled with a microTOF-Q II for MS analysis in the 
positive mode. 
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Yeast transformation 
INVSc1 S. cerevisiae was inoculated into 30 mL of YPD with shaking overnight 
at 30oC. Then, 2 mL of culture was transferred to 30 mL of YPD to make a final OD600 
of 0.1. The culture was incubated with shaking at 30oC until OD600 reached 0.5 (at least 
two generations) followed by centrifugation at 3000 g for 5 min. The supernatant was 
discarded and 20 mL of water was added to resuspend the cells. The mixture was again 
centrifuged at 3000 g for 5 min and the supernatant was discarded. Finally, 500 µL of 
water was added to resuspend the cells. Concurrently, 360 µL of transformation mix was 
prepared. The composition of the transformation mix is 240 µL of 50% W/V of 
PEG3550, 36 µL of 1 M of LiOAc, 50 µL of boiled single strained carrier DNA (2 
mg/mL) (Salmon sperm DNA, Sigma), and 34 µL of YesNTA2 plasmid solution 
containing the ScTHI5 gene in water. 100 µL of resuspended cell solution was mixed 
with 360 µL of the transformation mix. The mixture was vigorously vortexed and 
incubated in a 42oC water bath for 40 min. Then the mixture was centrifuged at 14000 
rpm for 30 sec and the supernatant was removed. Finally, 1 mL of water was added to 
resuspend the cells, and the cell solution was plated on SC-Ura selection medium and 
incubated at 30 °C for two to three days. 
 
Overexpression and purification of ScTHI5p in INVSc1 S. cerevisiae 
After successful transformation, the colony was inoculated in 30 mL of Sc-Ura 
containing 1% raffinose and 2% galactose and grown until turbid. Then the culture was 
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added into 1.5 L of the same media and grown an additional 3 days. Cells were 
harvested by centrifugation and stored at -80 °C until purification. 
12 g of cell from 5 L of culture was thawed and resuspended in lysis buffer with 
2 tablets of protease inhibitor cocktail (cOmplete EDTA free, Roche). The cells were 
lysed using a microfluidizer processor (M110P, Microfluidics) with 28000 psi three 
times. The resulting cell lysate was clarified by centrifugation and the THI5 protein was 
purified on a Ni-NTA column following the manufacturer’s instructions. The purified 
THI5p solution was buffer-exchanged to a desalting buffer (100 mM Tris, 30% glycerol, 
pH 7.5) and stored at -80 °C. 
 
 
Results and discussion 
Identification of the modified His66 of inactive THI5p 
 In the previous chapter, His66 of THI5p was identified as N=C-N donor for 
HMP-P formation. However, there was no literature report about the structure of 
histidine after HMP-P formation. Furthermore, this reaction is unprecedented in terms of 
chemistry and biochemistry, making it important to find an approach to identify it 
experimentally. 
 The strategy for this identification was to digest inactive THI5p followed by LC-
MS and MS/MS analysis (Figure 4-2). The candidate peptide containing the modified 
His66 was residues 63-71. Because there was no proposed structure for the modified 
His66, extracted ion chromatography (EIC) could not be used to identify the desired 
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peptide. However, the MS/MS analysis of residues 63-71 of the native peptide (the 
sequence is AMVHTLAAK) gave a very helpful hint. The signals of a2, b2 and y2 ions of 
this peptide were always good. In addition, these three ions corresponded to AM at the 
N-terminus and AK at the C-terminus. In the predicted peptide lists of THI5p by trypsin, 
only peptide 63-71 has these three ions present at the same time. Hence, the EIC was 
used in the MS/MS analysis to identify the appearance of these three ions at the same 
retention time. Finally, a peptide which [M+2H]2+ is 474.2 Da was selected for further 
investigation.  
 This peptide was 5.96 Da larger than the native peptide 63-71. In order to solve 
the peptide sequence, we assumed +5.96 Da at His66 to assign the corresponding ions in 
the MS/MS spectrum. Most of ions could be assigned to confirm the peptide sequence 
with modified His66 (labeled as X in Figure 4-2). The most important information was 
the y5 ion of this peptide corresponding to the fragment from the C-terminus to Thr67 
was identical to y5 ion of the native peptide 63-71. The y6 ion of this peptide was 6 Da 
larger than the y5 ion of the native peptide 63-71.  
 In order to analyze the MS/MS spectrum correctly, inactive 15N-THI5p was 
applied with the same analysis. In the MS/MS spectrum, all of ions had molecular 
weight (MW) shifts due to 15N incorporations. Moreover, the most informative thing is 
that the MW difference of the inactive 15N-THI5p between y5 and y6 was 144 Da 
compared with 143 Da in inactive 14N-THI5p, suggesting that there is one nitrogen atom 
at the modified His66. This 1 Da shift was due to the 15N of the amide. His66 contains 
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three nitrogen atoms, so these results indicate that the modified His66 does not contain 
the two nitrogen atoms on the imidazole ring.  
All of analysis indicated that His66 increased by 6 Da after HMP-P formation. 
Furthermore, it was also the first direct evidence to show His66 is the N=C-N donor. 
 
 
Figure 4-2. The MS/MS spectra of peptides for peptide 63-71 (A), modified peptide 63-
71 (B), and 15N-modified peptide 63-71 (C). 
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Characterization of the modified His66 
 The results indicated that His66 gains 5.96 Da after HMP-P formation, but the 
lack of structural information for the modified His66 (X), meant that the only approach 
was to test the functional groups on the modified His66. First I tested for the presence of 
ketone or aldehyde group which could be reduced by NaBH4. This would result in a 2 
Da increase after NaBH4 treatment. Therefore, the pool of the peptides derived from 
trypsin digestion of the inactive THI5p was treated with excess of NaBH4 followed by 
LC-MS analysis. The EIC was able to identify a peptide with a 2 Da increase and the 
MS-MS analysis confirmed the peptide sequence with 7.96 Da increase at His66 (Figure 
4-3A). The MW difference between the y5 and y6 ions were 145 Da compared with the 
previous spectrum. It indicated that the MW increase was from the modified His66 
implying that the modified His66 has a ketone or an aldehyde group.  
 Because of this, the aminooxy-biotin tag, which is used to study glycoproteins by 
the formation of oxime, was also used to enrich the peptide containing the modified 
His66 (Figure 4-3 B) 21. The pool of the peptides derived from the trypsin digestion of 
the inactive THI5p was incubated with the tag followed by avidin resin enrichment. LC-
MS analysis was used to detect the resulting peptide, however, the peptide signal was 
insufficient to get the MS/MS spectrum. But when the same procedure was applied on 
the inactive 15N-THI5p, LC-MS analysis was able to detect the 15N-peptide with 10 Da 
shift, implying that 10 nitrogen atoms remained on that peptide after His66 donated two 
nitrogen atoms from the imidazole ring for HMP-P synthesis. 
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Figure 4-3. (A) The MS/MS spectrum of modified peptide with NaBH4 treatment 
showing X with +2 Da. (B) The MS spectra of 14N- and 15N-modified peptide with the 
aminoxy-biotin tag. 
 
 
 During the aminoxy-biotin tag investigation, biotin hydrazide was used to enrich 
the modified peptide by the formation of hydrazone and EIC was used to analyze the 
corresponding peptide. But it was the MS/MS spectrum that proved the most important 
and interesting (Figure 4-4A). The spectrum confirmed the peptide sequence and that 
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there were a few ions showing -44 Da for the predicted ions. This implied that the 
hydrazone was involved in decarboxylation during CID fragmentation.  
 The results led to the postulation that the structure of the modified histidine is a 
keto-acid. This proposed structure corresponds with a 5.96 Da increase and a ketone 
group. Concerning the decarboxylation in the MS/MS fragmentation, biotin hydrazide 
forms hydrazone followed by tautomerization (Figure 4-4B), which could readily 
undergo decarboxylation. This may be applicable to proteomic studies of biological 
compounds containing keto-acids. 
 
 
Figure 4-4. (A) The MS/MS spectrum of modified peptide with biotinhydrazide 
showing the decarboxylation fragment. (B) The proposed mechanism of decarboxylation 
suggests a keto-acid structure. 
 
 
 52 
 
 
Synthesis of the reference peptide 
 By using NaBH4 and biotin hydrazide, the structure of His66 after HMP-P 
synthesis was proposed as its imidazole becomes a keto-acid. Although the peptide 
analysis were quite convincing, this enzymatic reaction is unprecedented. I decided to 
synthesize the reference peptide to compare it to the modified peptide.  
 The synthetic route is shown in Scheme 4-1. Protected glutamate 4-4 was reacted 
with (cyanomethylene)triphenylphosphorane 4-5 in the presence of EDCI to form cyano-
keto phosphorane 4-6 22. It underwent oxidative cleavage with ozone in the presence of 
methanol to form an α-keto ester product 4-7. The α-keto ester product 4-7 was 
deprotected by hydrogenolysis to generate 4-8, which was then protected by 
methoxyamine to conduct solid phase peptide synthesis 23,24. Finally, the ester of the α-
keto ester of the peptide 4-10 was hydrolyzed under a basic condition to generate the 
reference peptide 4-11.  
Since the reference peptide had oxime protection by methoxyamine, the pool of 
peptide containing the modified-His66 peptide was incubated with an excess of 
methoxyamine. Finally, the resulting peptide could be co-migrated with the reference 
peptide by LC-MS and MS/MS analysis. The EIC analysis showed that these two 
peptides co-migrated well. Most importantly, the MS/MS analysis of these two peptides 
showed identical fragmentation. These results confirm that the imidazole of His66 
becomes a keto-acid after HMP-P synthesis. 
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Scheme 4-1. The synthetic route of reference peptide 4-11. 
 
 
 
Figure 4-5. (A) The EIC analysis of co-migration. (B) The MS/MS spectra of the native 
peptide with methoxyamine and the reference peptide showed identical fragmentation. 
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Oxygen labeling of the His66-derived keto-acid  
 The THI5p assay requires O2 to generate HMP-P. Because the His66-derived 
keto-acid contains oxygen atoms, we wanted to identify the source of the oxygen atoms. 
The full reaction assay was incubated under an atmosphere of 18O2 followed by peptide 
analysis (Figure 4-6).  
 
 
Figure 4-6. (A) The MS spectrum of the modified peptide showing two 18O 
incorporations. (B) The MS/MS spectra of the modified peptide derived from 16O2 and 
18O2 atmosphere to identify 18O incorporation at the His66-derived keto-acid. 
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Surprisingly, the MW of the modified peptide had +4 Da corresponding to two 
18O incorporations. Notably, the spectrum included non-labeled peptide because THI5p 
underwent the full reaction during overexpression. This did not hinder the MS/MS 
spectra which showed that the y6 ion had a 4 Da increase in the 18O-labeled peptide 
indicating 18O incorporation at the modified His66.  
 However, the keto-acid structure has three oxygen with two 18O incorporations. 
There are two possible patterns for 18O incorporation: two 18O at the carboxylic acid or 
one 18O at the ketone and one 18O at the carboxylic acid. To determine where 
incorporation was occurring we used methoxyamine to form an oxime in the 18O-labeled 
modified peptide (Figure 4-7). The resulting peptide still had +4 Da indicating 
incorporation of the two 18O at the carboxylic acid. 
 
 
Figure 4-7. The 18O incorporating peptide with methoxyamine treatment to identify 18O 
incorporating positions at the carboxylic acid. 
 
 
 Since there are two 18O incorporating at the carboxylic acid of the keto-acid, it is 
interesting to know whether these two 18O were derived from the same or different O2. 
The assay was incubated under an atmosphere composed of a mixture of 16O2 and 18O2 
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and the MW of the modified peptide was analyzed (Figure 4-8). Interestingly, the 
isotope distribution of the MW of the modified peptide indicated the presence of 16O/ 
16O, 16O/ 18O, and 18O/ 18O labeling meaning that the two oxygen atoms in the carboxylic 
acid are from two different O2. 
Figure 4-8. The MS spectrum of modified peptide derived from the mixture of 16O2 and 
18O2 atmosphere.  
In vivo investigation of the presence of keto-acid in THI5p 
The characterization of the His66-derived keto-acid was accomplished in vitro. 
But is the His66-derived keto-acid formed in vivo? To investigate this ScTHI5p was 
overexpressed in both S. cerevisiae and S. cerevisiae ΔTHI5. Each was grown in 
minimal media without thiamin supplementation. The overexpressed THI5p was purified 
by Ni-NTA chromatography, digested by trypsin, and analyzed by LC-MS. The 
candidate peptide sequence (AMIHTLAAK) was different from CaTHI5p 
(AMVHTLAAK), but the EIC analysis can identify the desired peptide using the 
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predicted MW. The MS/MS analysis confirmed the peptide sequence and the y6 ion 
showed a 6 Da increase compared with the original peptide (Figure 4-9).  
 
 
Figure 4-9. The MS/MS spectra of the S. cerevisiae original peptide (A), modified 
peptide (B), and modified peptide with biotin hydrazide (C). 
 
 
All of experiments were repeated with the same result. These experiments 
indirectly demonstrated the His66-derived keto-acid forms after HMP-P formation. 
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Identification of the PLP by-product 
The feeding studies demonstrated that PLP partially incorporates into HMP-P. 
The question is what PLP by-product forms after HMP-P formation? PLP has an 
aldehyde group that forms an imine with Lys62 and this aldehyde does not incorporate 
into HMP-P. We tested the hypothesis that the PLP by-product might retain this 
aldehyde group. Normally, 2,4-dinitrophenylhydrazine is normally used to trap aldehyde 
with the formation of hydrazone, which has a unique λmax between 300 to 400 nm. This 
specific λmax monitored by HPLC analysis could readily identify trapping compounds. 
However, 2,4-dinitrophenyl hydrazine does not dissolve very well in an aqueous buffer, 
and can damage the reverse phase column. Furthermore, the assay conditions are acidic 
which might degrade acid sensitive substrates. Therefore, phenylhydrazine was chosen 
for this investigation because of its good solubility in aqueous solution and neutral assay 
conditions. 
After completion of the reaction, the protein was removed followed by the 
addition of phenylhydrazine solution. Finally the mixture was analyzed by HPLC 
monitored at 350 nm. The HPLC analysis showed one peak in the THI5p wild-type full 
reaction instead of other three control samples (Figure 4-10).  
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Figure 4-10. The HPLC analysis of phenylhydrazine trapping of the PLP by-product. 
Moreover, the THI5p H66G and K62Y proteins did not have this peak in HPLC 
analysis. This peak was collected and analyzed by LC-MS (Figure 4-11). Surprisingly, 
the collected pool contained two compounds, which were separated by the small particle 
size column used for LC-MS. The first peak was identified by MS and MS/MS as a 
glyoxylate and phenylhydrazine adduct; the reference compound was synthesized to 
conduct a co-migration experiment. The second peak based on the MS and MS/MS 
analysis was proposed to be a C3-fragment and phenylhydrazine adduct. In this case the 
reference compound was not made because of the difficulty of the synthesis. However, 
the MS/MS analysis gave enough information to assign the adduct structure.  
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Figure 4-11. The LC-MS and MS/MS analysis of the PLP by-product identified as 
glyoxylate and a C3-fragment. 
To confirm these two molecules were derived from the THI5p catalyzed reaction, 
4’,5’-13C-PLP was used to set up the full reaction assay. The MW of HMP-P had +1 Da 
as the prediction to suggest the reaction works well. In the meantime, the assay after the 
removal of THI5p was derivatized by phenylhydrazine. Finally, the pool containing 
these two adducts was collected and analyzed by LC-MS (Figure 4-12). The MW of the 
C3-fragment adduct showed +1 Da. Likewise, the MS of the glyoxylate adduct also had 
a 1 Da increase based on isotopic distribution. The reason the glyoxylate adduct did not 
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have a complete [M+1]+ signal is because the glyoxylate was present in both Eppendorf 
tubes and glycerol. Therefore, the assay using 4’,5’-13C-PLP could further confirm that 
these two molecules derived from PLP. Moreover, the MS/MS analysis of these two 
adducts could identify the position of 13C. In both of adducts, the 13C was at the imine 
carbon, suggesting that the aldehyde group of PLP is retained after HMP-P formation. 
Figure 4-12. The MW analysis of glyoxylate (A) and the C3-fragment (B) with the 
phenylhydrazine derivative showing one 13C incorporation from 4’,5’-13C-PLP. 
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Decarboxylation of the C3-fragment to generate glyoxylate 
 In the phenylhydrazine trapping experiments, two molecules were identified as 
PLP by-products, but the final product was proposed to be glyoxylate. To compare these 
two molecules, it was proposed that the C3-fragment containing keto-acid undergoes 
decarboxylation to generate glyoxylate. In the literature, the decarboxylation of keto-
acid could undergo radical reaction, metal-assisted reaction involving radical, and H2O2-
catalyzed reaction 25,26.  
 During the course of the THI5p studies, other biochemical investigations 
suggested that H2O2 catalyzed the decarboxylation of the keto-acid. A pool of these two 
molecules and phenylhydrazine adducts was collected, treated with H2O2, and analyzed 
by HPLC (Figure 4-13). The HPLC analysis comparing the samples before and after 
H2O2 treatment showed that the glyoxylate adduct increased concomitant with the 
disappearance of the C3-fragment adduct. This suggested that H2O2 reacted with the C3-
fragment to form glyoxylate following decarboxylation. 
 
 
Figure 4-13. The HPLC analysis of the decarboxylation of the keto-acid catalyzed by 
H2O2. 
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Oxygen labeling of the C3-fragment and glyoxylate 
 Since the His66-derived keto-acid has two oxygen atoms incorporated by O2, we 
investigated oxygen labeling using the same strategy as for the THI5p peptide.  
 The full reaction assay was incubated under an atmosphere of 18O2. After the 
reaction was complete, the protein was removed followed by phenylhydrazine 
derivatization. The pool containing these two adducts was collected and analyzed by LC-
MS (Figure 4-14).  
 
 
Figure 4-14. The MS spectra of glyoxylate (A) and the C3-fragment (B) derived from 
the 18O2 atmosphere. 
 
 
The MW of the C3-fragment adduct increased by 2 Da corresponding to one 
oxygen incorporation. The MS/MS analysis identified the 18O position at the carboxylic 
acid. In addition, the MW of the glyoxylate adduct showed 2 and 4 Da increase. The 
partial incorporation suggested that solvent exchange had occurred. Therefore, 18O-water 
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was used to investigate the exchangeable group. The mixture of these two adducts was 
lyophilized completely and redissolved in 18O-water. The glyoxylate adduct did not 
show any incorporation of 18O, but the C3-fragment adduct had one 18O incorporation 
and the MS/MS analysis identified that it incorporated at the ketone. Moreover, the 
results also indicated that the carboxylic acid does not undergo solvent exchange.  
 The full reaction assay was set up in the buffer containing 60% 18O-water. After 
phenylhydrazine derivatization, the mixture was analyzed by LC-MS (Figure 4-15). The 
MW of the C3-fragment adduct showed about 60% 18O incorporation. The MW of the 
glyoxylate adduct showed the incorporation of only one 18O. Thus, the solvent exchange 
happened before phenylhydrazine derivatization. But it explains why the MW of the 
glyoxylate adduct in the 18O2 assay showed both one and two 18O incorporations.  
 
 
Figure 4-15. The MS spectra of glyoxylate (A) and the C3-fragment (B) derived from 
60% 18O-water conditions. 
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 To summarize these labeling results, the positions of oxygen incorporation are 
shown in Scheme 4-2. 
 
 
Scheme 4-2. The oxygen labeling pattern of glyoxylate (A) and the C3-fragment (B). 
 
 
Conclusion 
 In this chapter, the His66 structure and PLP by-products after HMP-P formation 
were characterized. The imidazole of His66 becomes a keto-acid and the PLP by-product 
goes through the C3-fragment as an intermediate to generate glyoxylate after 
decarboxylation. Oxygen incorporates into both the keto-acid and glyoxylate. This will 
help us complete the picture of the mechanism of HMP-P formation (Scheme 4-3).  
 The reaction is initiated by the formation of a phenolic radical 4-12. The radical 
adds to the imidazole ring of His66 to form 4-14 followed by the addition to C5 of PLP 
to generate 4-15. 4-15 reacts with O2 to form a superoxide radical 4-16 followed by 
hydrogen abstraction to generate 4-17. The peroxy group of intermediate 4-17 attacks 
the ketone to form 4-18. The intermediate 4-18 undergoes a series of β-scission reactions 
to generate 4-21 and 4-22. The keto-acid intermediate 4-22 reacts with hydrogen 
peroxide to undergo decarboxylation which generates glyoxylate 4-25. Hydrogen 
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peroxide is proposed to be generated from oxygen reacts with di-ferrous (the 
investigation of di-ferrous on THI5p is in Chapter 7). The structure of 4-22 is similar to 
the C3-fragment with phenylhydrazine. The investigation of the PLP by-product could 
support this part of proposed mechanism. 
4-21 becomes 4-28 after resonance and tautomerization. The intermediate 4-28 
reacts with another O2 to generate 4-29. The superoxide radical of 4-29 attacks iminium 
to form 4-30 followed by deprotonation to break the O-O bond to generate 4-32. 4-32 
undergoes 1e- oxidation and deprotonation to form 4-33 followed by an attack of water 
to generate 4-34. The water is proposed to be the by-product from O2 catalyzed by iron. 
Finally, 4-34 undergoes elimination to generate the His66-derived keto-acid 4-35 and 
HMP-P 4-3. This proposed mechanism matches the labeling results in the 18O2 
experiments. 
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Scheme 4-3. The proposed mechanism of HMP-P formation catalyzed by THI5p. 
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CHAPTER V 
INVESTIGATION OF THE PLP-DERIVED SHUNT REACTION AND 
MODIFICATIONS ON THI5 PROTEIN 
Introduction 
In the last two chapters, the reconstitution of THI5p activity and the 
characterization of the modified His66 and PLP by-products after HMP-P formation 
were explored. Moreover, oxygen is also incorporated into the His66-derived keto-acid 
and PLP by-products. In this chapter, a PLP shunt product was identified to support a 
radical initiation mechanism. Cys199 and Met320 were oxidized during HMP-P 
formation. Lastly, 2-oxo-histidine was characterized as a by-product.  
Experimental methods 
PLP-nitrile identification 
100 µL of 600 µM THI5p was anaerobically pre-incubated with 2 molar 
equivalents of Fe(NH4)2(SO4)2 in an ice bath for 30 min. The mixture was anaerobically 
desalted using a Bio-Spin 6 column (Bio-Rad) pre-equilibrated with 100 mM Tris-HCl, 
pH 7.5, followed by the addition of 2 molar equivalents of PLP. The reaction mixture 
was aerobically incubated at room temperature for 3 h, filtered using a 10 kDa MW cut-
off filter, and analyzed by HPLC and LC-MS. 
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HPLC conditions for analyzing and isolating PLP-nitrile 
The following linear gradient was used, at a flow rate of 2 mL/min, on a 
Supelcosil LC-18 column (250 mm X 10 mm, 5 µm ID): solvent A is water, solvent B is 
100 mM KH2PO4, pH 6.6, solvent C is methanol; 0 min: 100% B; 5 min: 10% A, 90% 
B; 10 min: 25% A, 60% B, 15% C; 13 min: 25% A, 60% B, 15% C; 17 min: 30% A, 
10% B, 60% C; 18 min: 30% A, 10% B, 60% C; 21 min: 100% B. For the isolation, 
solvent B is 100 mM NH4OAc, pH 6.6. 
Preparation of THI5p hydrolysate for 2-oxo-histidine investigation 
100 µL of 600 µM THI5p was anaerobically pre-incubated with 2 molar 
equivalents of Fe(NH4)2(SO4)2 in an ice bath for 30 min. The mixture was anaerobically 
desalted using a Bio-Spin 6 column (Bio-Rad) pre-equilibrated with 100 mM Tris-HCl, 
pH 7.5. The reaction mixture was aerobically incubated at room temperature for 3 h. 
Then the mixture was buffer exchanged to 20 mM ammonium bicarbonate using a Bio-
Spin 6 column. The resulting solution was dried by lyophilization and redissolved in 2 
mL of 6 M HCl and 40 mM DTT. The mixture was refluxed at 105 °C for 24 h and dried 
by lyophilization. The resulting solid was redissolved in water containing 0.1% acetic 
acid for further investigation. 
HPLC conditions for isolating the fraction containing 2-oxo-histidine 
The following linear gradient, at a flow rate of 1 mL/min, on a Supelcosil LC-18-
T column (150 mm X 4.6 mm, 5 µm ID) was used: solvent A is water containing 0.1% 
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acetic acid, solvent B is acetonitrile containing 0.1% acetic acid; 0 min: 100% A; 5 min: 
100% A; 10 min: 100% B; 13 min: 100% B; 16 min, 100% A; 25 min, 100% A. 
Ortho-phthaldialdehyde (OPA) derivatization of amino acid analysis 
25 µL of THI5p hydrolysate or 2-oxo-hisitinde solutions was added into 30 µL of 
20 mM OPA, 1 M potassium borate, pH 8.0, 60 mM β-mercaptoethanol, 1.5% methanol. 
The mixture was incubated at room temperature for 1 min and then analyzed by HPLC. 
HPLC conditions for analyzing OPA derivatization of THI5p hydrolysate 
The following linear gradient, at a flow rate of 2 mL/min, on a Supelcosil LC-18 
column (250 mm X 10 mm, 5 µm ID) was used: solvent A is 50 mM NaCl, solvent B is 
methanol; 0 min: 100% A; 16 min: 75% A, 25% B; 22 min: 60% A, 40% B; 25 min, 
50% A, 50% B; 31 min, 45% A, 55% B; 35 min, 25% A, 75% B; 40 min, 25% A, 75% 
B; 43 min, 100% A; 53 min, 100% A.  
Results and discussion 
Identification of PLP-derived shunt product 
During investigating the reconstitution of THI5p, HPLC analysis monitored at 
230 nm occasionally showed a peak near the void volume and the UV spectrum of this 
peak was similar to PLP (Figure 5-1). After careful investigation, this peak reached a 
maximum when the assay did not contain DTT. Moreover, this peak was derived from 
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an enzymatic reaction. Heat-denatured THI5p cannot generate this under the same 
conditions. 
 
 
Figure 5-1. (A) The generation of a PLP-derived shunt product under low concentration 
of DTT or no DTT. (B) PLP-derived shunt product generated by active THI5p. (C) UV 
spectra of the PLP-derived shunt product and pyridoxal analogues.  
 
 
 The corresponding fraction was collected by HPLC and then analyzed by LC-
MS. The [M+H]+ of this compound was 245.0 Da (Figure 5-2A). Interestingly, the 
MS/MS spectrum suggested this compound had a phosphate group. This was confirmed 
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by the treatment of calf intestinal phosphatase (CIP). The retention time of this 
compound in HPLC analysis shifted after CIP treatment (Figure 5-2B). This suggested 
that this compound might have a PLP like structure. We used 15N-THI5p to test whether 
there was a MW shift of this compound and found that the MW increased by 1 Da 
(Figure 5-2A), but the PLP added was not 15N-labeled, implying that 15N-THI5p donated 
one 15N.  
 
 
Figure 5-2. (A) PLP-derived shunt product generated by 14N- and 15N-THI5p. (B) PLP-
derived shunt product has a phosphate group. 
 
 
 Therefore, the structure was proposed as PLP-nitrile 5-6 (Scheme 5-1). The 
reference compound without the phosphate group was synthesized by Dr. Dmytro 
 73 
 
 
Fedoseyenko. The reference compound co-migrates with this compound after CIP 
treatment (Figure 5-3). 
 
 
Figure 5-3. The co-migration experiments for the PLP-derived product and reference 
compound. 
 
 
 The formation of PLP-nitrile 5-6 could support that HMP-P synthesis is initiated 
by radical generation (Scheme 5-1). 5-1 undergoes 1e- oxidation to generate 5-2. 
Phenolic radical of 5-2 attacks the imine to form 5-3. After 1e- oxidation, 5-4 is formed 
to undergo deprotonation to generate 5-5. A nucleophile attacks 5-5 to generate 5-6.  
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Scheme 5-1. The proposed mechanism of PLP-nitrile 5-6 formation 
 
 
C199 and M320 oxidation 
 In the THI5p crystal structure, the active-site structure shows that PLP forms an 
imine with Lys62, located near His66. In the sequence alignment of THI5p homologs, 
the sequence LGCCCFC (residues 193~199) is highly conserved. In the in vitro studies, 
any of these four cysteines after mutagenesis would abolish HMP-P production, 
indicating the essential nature of the existing interactions. After the THI5p full reaction, 
the inactive THI5p was treated with iodoacetamide to protect the cysteines followed by 
trypsin digestion. LC-MS analysis identified one corresponding peptide with +48 Da 
(Figure 5-4), suggesting cysteine oxidation. MS/MS analysis identified that the C199 
thiol becomes a sulfonic acid. These findings were analyzed by MALDI-TOF MS and 
MS/MS analysis.  
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Figure 5-4. Identification of C199 oxidation: (A) ESI-MS/MS confirms the peptide 
sequence. (B) MALDI-TOF MS/MS identifies y10 ion corresponding to C199 oxidation. 
 
 
 A peptide containing M320 was also found showing a 16 Da (Figure 5-5) 
increase in MW. Under an atmosphere of 18O2, this peptide showed a +2 Da shift derived 
from 18O incorporation. Unfortunately the MS/MS spectrum could not identify the 
position, but M320 was the only residue that could be oxidized. 
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Figure 5-5. The MS analysis of peptide corresponding M320 oxidation under 
atmosphere of 16O2 (A) and 18O2 (B). 
 
 
Intact protein molecular weight of the inactive THI5p 
 We have discussed three modifications in inactive THI5p. They are at His66, 
Cys199, and Met320 which were identified by the peptide analysis. If all the MW shifts 
are added, the MW of THI5p would increase by about 70 Da if HMP-P formation 
resulted in these modifications. During the course of THI5p studies, the assay conditions 
were improved to generate more HMP-P. Because the activity of THI5p is better, it 
resulted in fewer protein species after HMP-P formation. Finally, the intact protein MW 
of inactive THI5p was measured and showed an increase of 70 Da than the THI5p 
calculated MW (Figure 5-6). 
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Figure 5-6. The intact MW analysis of apo-THI5p (A) and inactive THI5p after HMP-P 
synthesis (B). 
 
 
Identification of 2-oxo-histidine  
 During the course of peptide analysis, one peptide derived from the control assay 
(THI5p+Fe no DTT) had an attractive MS/MS spectrum (Figure 5-7) with similar 
signals as the a2, b2 and y2 ions of the modified peptide. Interestingly, the MW of this 
peptide is 16 Da more than the native peptide. The MS/MS analysis of this peptide 
indicated the sequence comprises residues 63-71, and that His66 has a modification 
increasing it by 16 Da. To test whether +16 Da derived from oxygen gas, the assay was 
incubated under an atmosphere of 18O2, which showed 18O incorporated into the 
modified His66. 
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Figure 5-7. The MS/MS analysis of the peptide containing 2-oxo-histidine. 
 
 
 The oxidation of histidine on the protein can occur under oxidative stress 
conditions. One of the structures is 2-oxo-histidine derived from the hydroxyl        
radical 27,28. In order to test the presence of 2-oxo-histidine, after the assay THI5p was 
hydrolyzed for 24 h at 105 °C in the presence of 6 M HCl solution with 40 mM DTT 
(Figure 5-8). After removing the solvent, the sample was redissolved in 0.1% acetic acid 
and subjected to LC-MS analysis for the co-migration. The reference compound was 
made by Dr. Dmytro Fedoseyenko. The EIC analysis showed good co-migration, and the 
MS/MS spectrum of this compound was identical to that reported in the literature 29. 
 Ortho-phthalaldehyde (OPA) was used to derivatize 2-oxo-histidine to conduct 
the co-migration. Since the mixture of hydrolysate contained a lot of small molecules, 
the fraction containing 2-oxo-histidine was collected by HPLC. After removing the 
solvent, OPA derivatization was performed on the purified hydrolysate and the reference 
compound. The mixture was analyzed by HPLC monitored at 340 nm (Figure 5-9). The 
HPLC analysis suggested that the purified hydrolysate contained 2-oxo-histidine. 
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Figure 5-8. The MS (A) and MS/MS (B) analysis of 2-oxo-histidine in THI5p 
hydrolysate.  
 
 
 
Figure 5-9. The co-migration experiments by ortho-phthalaldehyde (OPA) 
derivatization to identify 2-oxo-histidine generation in THI5p. 
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 The identification of 2-oxo-histidine constitutes indirect evidence of the presence 
of H2O2 which catalyzes the decarboxylation of the C3-fragment to generate glyoxylate. 
H2O2 generation is proposed to occur when O2 reacts with a di-ferrous. 
  
Identification of C199 oxidation and 2-oxo-histidine in ScTHI5p 
Like the His66-derived keto-acid, do C199 and His66 become oxidized in vivo? 
Since ScTHI5p was overexpressed in S. cerevisiae, ScTHI5p digested by trypsin was 
analyzed by LC-MS.  
 For C199, the corresponding peptide with an increase of 48 Da was identified by 
EIC. The MS/MS spectrum confirmed the sequence (Figure 5-10), but could not identify 
the oxidized residue. Thus, it was implied that cysteine oxidation occurs, but was not 
proven conclusively. 
 
 
Figure 5-10. The MS/MS analysis of the peptide containing possible C199-sulfonic 
acid. 
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Figure 5-11. The MS/MS analysis of the S. cerevisiae peptide containing His66 (A) and 
His66-derived 2-oxo-histidine (B). 
 
 
For His66, the corresponding peptide with +16 Da was identified by EIC. The 
MS/MS analysis confirmed the sequence and identified +16 Da at His66 (Figure 5-11). 
But this modification is not part of HMP-P formation. I have no explanation for the 
function of this modification. It is also possible that it is just an artifact. 
 
H66C oxidation 
 His66 could receive the 2-oxo-histidine modification under non HMP-P 
production assays. If His66 was mutated to a residue that was easily oxidized, what 
modification would occur? To test this, the THI5p H66C was mutated to a cysteine using 
the same conditions as for the generation of 2-oxo-histidine. Cysteine can be oxidized to 
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sulfenic, sulfinic, or sulfonic acid. Sulfonic acid is the most stable product for cysteine 
oxidation. Therefore, the first candidate peptide was to look for a 48 Da increase using 
EIC. However, the corresponding peptide was not found. Interestingly, the peptide with 
+32 Da was identified suggesting the generation of sulfinic acid (Figure 5-12), which is 
unexpected given its lesser stability. At this moment, these data cannot be interpreted.  
 
 
Figure 5-12. The MS/MS analysis of the peptide containing H66C with +32 Da. 
 
 
Conclusion 
 In this chapter, I have discussed several modifications of THI5p. C199 and M320 
oxidation occur as part of HMP-P formation. Moreover, C199 is conserved in all THI5p 
homolog and C199 mutants cannot generate HMP-P, suggesting that C199 plays an 
important role in HMP-P formation. It has been proposed that C199’s function involves 
the electron transfer that initiates HMP-P formation, but a definitive answer awaits 
further investigation. 
 The formation of 2-oxo-histidine suggests the presence of H2O2 which could 
support decarboxylation of the C3-fragment. The most important discovery is the 
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identification of PLP-nitrile. The unexpected nitrogen incorporation is derived from 
THI5p from the generation of a phenolic radical involving HMP-P formation. 
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CHAPTER VI 
IDENTIFICATION OF BOUND INTERMEDIATES ON THI5 PROTEIN 
 
Introduction 
 The mechanistic investigation of HMP-P synthesis catalyzed by THI5p is 
complicated due to His66’s involvement in the reaction. Though HPLC analysis does not 
identify any shunt products in the small molecule pools, it does not rule out formation of 
shunt intermediates on the protein. Molecular weight analysis of the intact protein does 
not provide a definitive identification because there are other modifications and PLP 
bound to the protein. Moreover, very small modifications to the entire protein could not 
be identified due to sensitivity.  
 In this chapter, the radioactive approach was developed to identify shunt 
intermediates on THI5p. After trypsin digestion of protein, Fe-NTA chromatography 
was used to enrich phosphopeptides containing shunt intermediates which were analyzed 
by LC-MS and MS/MS. Preliminary characterization of the peptides were completed to 
make proposed structures of shunt intermediates.  
 
 
Experimental methods 
Preparation of 32P-pyridoxal-5’-phosphate (32P-PLP) 
12 µL of 10 mM pyridoxal was added to 50 µL of PdxK (pyridoxal kinase), 24 
µL of 10 mM ATP and 5 µL of γ-32P-ATP (10 Ci/mmol). Then 2 µL of 0.1 M MgCl2 
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was added to initiate the phosphorylation. The reaction mixture was incubated at 37 °C 
for 2 h. Finally, the mixture was filtered with a 10 kDa cut-off filter. The filtrate was the 
stock solution of 32P-PLP for further uses. 
 
Detection of bound intermediates in the THI5p full reaction assay by phosphoimager 
100 µL of 600 µM THI5p or variants were anaerobically pre-incubated with 2 
molar equivalent of Fe(NH4)2(SO4)2 in an ice bath for 30 min. The mixture was 
anaerobically desalted using a Bio-Spin 6 column (Bio-Rad) pre-equilibrated with 100 
mM Tris-HCl, 5 mM DTT, pH 7.5. Subsequently, 1 µL of 32P-PLP stock solution and 2 
molar equivalents of PLP were added. The mixture was incubated at room temperature 
for 3 h. After the reaction finished, 10 µL of the reaction mixture was added into 10 µL 
of SDS buffer (20% glycerol, 4% SDS, 100 mM Tris, pH 7.4). Then the mixture was 
incubated at 90 °C for 5 min. After the mixture was cooled, 10 µL of 500 mM 
methoxyamine, pH 7.0 was added and incubated at room temperature for 30 min. 
Finally, 150 µL of 100 mM Tris, pH 7.4 was added to dilute the mixture. 10 µL of the 
diluted mixture was used to run SDS-PAGE. The gel was dried by the gel dryer system 
(Bio-rad) and placed in the exposure cassette with a phosphoscreen for 1 h. The 
phosphoscreen was analyzed using a Typhoon scanner (GE health life science). 
 
Small scale phosphopeptide enrichment  
After the THI5p full reaction assay was completed, the mixture was buffer-
exchanged to 20 mM ammonium bicarbonate by Bio-Spin 6 column (Bio-Rad). Trypsin 
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was added to digest THI5p at 37 °C overnight at a 1:50 ratio of trypsin to THI5p. Then 
the solution was dried by a speedvac concentrator (Thermo Scientific). The Fe-NTA 
phosphopeptide enrichment kit (Pierce) was used to enrich the resulting peptide mixture, 
followed by LC-MS analysis. 
 
Large scale phosphopeptide enrichment 
After THI5p purification, 3 mL of 1 mM THI5p was incubated with 1 mL of 10 
mM PLP. Then the mixture was desalted under anaerobic conditions using a 10DG 
column (BioRad) pre-equilibrated with 100 mM Tris-HCl buffer, 30% glycerol, pH 7.5. 
Three molar equivalents of Fe(NH4)2(SO4)2 were added into the resulting THI5p solution 
in an ice bath for 30 min. The mixture was anaerobically desalted using a 10DG column 
(Bio-Rad) pre-equilibrated with 100 mM Tris-HCl, 5 mM DTT, pH 7.5. Then the 
mixture was separated into 500 µL aliquots. Finally, 50 µL of air saturated buffer (100 
mM Tris-HCl, pH 7.5) was added aerobically and incubated at room temperature for 3 h.  
Following incubation, 3 mL of the reaction mixture was desalted by a 10DG 
column (Bio-Rad) pre-equilibrated with 20 mM ammonium bicarbonate, pH 8.0. Trypsin 
was added into the resulting THI5p solution and incubated at 37 °C overnight (the ratio 
of trypsin to THI5p was 1:50). Then the mixture was incubated at 60 °C for 30 min 
followed by cooling to room temperature. Trypsin was again added into the THI5p 
solution and incubated at 37 °C for another 8 h. Finally, the solution was dried by 
lyophilization. 
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The IMAC column for phosphopeptide enrichment was prepared using NTA-
Agarose (Qiagen). First, 20 mL of 0.2 M FeCl3 flushed NTA-Agarose followed by 20 
mL of water to remove unbound Fe3+. Finally, the Fe-IMAC column was equilibrated 
with the loading solution (6% acetic acid, pH 3.5). After lyophilization the sample was 
dissolved in the loading solution and vortexed vigorously followed by centrifugation at 
5000 rpm for 10 min. The supernatant was injected into Fe-IMAC column and washed 
with the washing buffer (90% loading buffer and 10% acetonitrile), followed by 
equilibration with the loading buffer. Finally, the bound peptides were eluted by 200 
mM NH4H2PO4, pH 4.4. The eluted peptides were dried by lyophilization and dissolved 
in 0.1% formic acid for LC-MS analysis or HPLC collection. 
 
 
Results and discussion 
Detection of bound intermediates by phosphoimager 
 In the proposed mechanism, most of the proposed intermediates are on the 
protein instead of existing as separate small molecules because His66 is the substrate for 
HMP-P formation. Therefore, the 32P-radiological experiments were applied to identify 
any shunt intermediates on the protein using phosphoimaging. 32P-PLP was made from 
pyridoxal with γ-32P-ATP catalyzed by pyridoxal kinase (PdxK). 32P-PLP was added into 
the THI5p or variants assays. After the reaction, the protein was heat-denatured in SDS 
buffer followed by the addition of methoxyamine. Without the addition of 
methoxyamine, ambiguous signals were derived from 32P-PLP forming an imine with 
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Lys62. Finally, the signals analyzed by phosphoimager were compared between the full 
and control reactions.  
 The imaging results showed that the signal in THI5p-WT full reaction assay was 
stronger than the other three control reactions (Figure 6-1A), which suggested the 
presence of shunt intermediates. Moreover, the full reactions in other THI5p variants 
also had stronger signals (Figure 6-1B).  
 
 
Figure 6-1. The phosphoimaging analysis of the THI5p-WT assays (A) and THI5p 
variant full reactions (B). Negative control: THI5+PLP followed by methoxyamine and 
NaBH4 reduction. Positive control: THI5p+PLP followed by NaBH4. 
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Identification of shunt intermediates on the THI5p wild-type 
 The phosphoimaging results suggested the presence of shunt intermediates in the 
THI5p-WT full reaction. However, we did not have structural information and did not 
know the identity of the modified residue. We decided to identify the residues first. 
Because the phosphoimager signals were derived by 32P, we knew the shunt 
intermediates had a phosphate group, so phosphopeptide enrichment was used 30. This is 
widely used method in proteomic research for phosphorylated proteins. Because 
phosphopeptide signals are not as strong as normal peptides, phosphopeptides must be 
enriched for MS identification. For THI5p, the enrichment by Fe-IMAC worked better 
than TiO2. It was used to enrich the phosphopeptide from the digestion sample of 
THI5p-WT from the full reaction 31. The control reaction was THI5p+PLP followed by 
the same enrichment procedure. Both samples were analyzed by LC-MS. After 
comparing the LC-MS analysis from these two samples, five peptides were identified 
with shunt intermediates (Figure 6-2 to 6-6). The MS/MS analysis of all five peptides 
showed two peptide sequences. The sequence of two peptides (A and B) were from 
Ala63 to Lys71 and contained His66. The sequence of three peptides (C, D, and E) were 
from Ala57 to Lys71 and contained both Lys62 and His66. These results were promising 
because they supported the proposed mechanism as any intermediate would have a 
covalent bond with His66. Moreover, four out of these five peptides had a phosphate 
group based on the loss of 98 Da fragment in the MS/MS analysis. 
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Figure 6-2. The MS and MS/MS analysis of peptide A. 
 
 
 
Figure 6-3. The MS and MS/MS analysis of peptide B. 
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Figure 6-4. The MS and MS/MS analysis of peptide C. 
 
 
 
Figure 6-5. The MS and MS/MS analysis of peptide D. 
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Figure 6-6. The MS and MS/MS analysis of peptide E. 
 
 
Identification of the five peptides derived from the enzymatic reaction 
 The peptide analysis suggested these five peptides might be candidates to study. 
But in order to confirm these peptides derived from THI5p reaction, 4’,5’-13C-PLP was 
used to set up the assays. Our hypothesis is that the peptides would have 13C 
incorporation if they were derived from shunt reactions. The MS analysis of these five 
peptides confirmed that 13C incorporated into all of peptides (Figure 6-7 to 6-11). 
Peptides A, B, and C had one 13C incorporation. Peptides D and E had two 13C 
incorporations. The results further confirmed that these five peptides contain shunt 
intermediates derived from the THI5 enzymatic reaction. 
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Figure 6-7. The MS and MS/MS analysis of peptide A with one 13C incorporation. 
 
 
 
Figure 6-8. The MS and MS/MS analysis of peptide B with one 13C incorporation. 
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Figure 6-9. The MS and MS/MS analysis of peptide C with one 13C incorporation. 
 
 
 
Figure 6-10. The MS and MS/MS analysis of peptide D with two 13C incorporations. 
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Figure 6-11. The MS and MS/MS analysis of peptide E with two 13C incorporations. 
 
 
Identification of the number of nitrogen at His66 
 In order to solve the structure of the shunt intermediates, I wanted to investigate 
whether the imidazole of His66 was intact or if N=C-N was donated to generate HMP-P. 
To discover this the number of nitrogen atoms can be identified by 15N-THI5p. 15N-
THI5p was used to set up the assays. After peptide analysis (Figure 6-12 to 6-16), 15N-
peptides A and B had both an increase of 12 Da compared with 14N-peptides A and B. 
Based on the peptide sequence, there are 12 nitrogen atoms, thus two nitrogen atoms of 
the His66 imidazole were retained in the shunt intermediates.  
 Moreover, 15N-peptides D and E had a 19 Da shift compared with 14N-peptides D 
and E. Based on the peptide sequence, there are 19 nitrogen atoms, and two nitrogen 
atoms of imidazole at His66 and the nitrogen of Lys62 were retained in the shunt 
intermediates. 
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 However, 15N-peptide C had only a 17 Da shift compared with 14N-peptide C. 
The peptide sequence indicates 19 nitrogen atoms meaning that two nitrogen atoms were 
lost during the reaction. I propose that two nitrogens from the imidazole of His66 were 
donated and the imidazole ring did not intact in the shunt intermediate. 
 
 
 
Figure 6-12. The MS and MS/MS analysis of 15N-peptide A. 
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Figure 6-13. The MS and MS/MS analysis of 15N-peptide B. 
 
 
 
Figure 6-14. The MS and MS/MS analysis of 15N-peptide C. 
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Figure 6-15. The MS and MS/MS analysis of 15N-peptide D. 
 
 
 
Figure 6-16. The MS and MS/MS analysis of 15N-peptide E. 
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Identification of the carboxylic acid on shunt intermediates 
 During investigation of the structures of shunt intermediates, the presence of 
carboxylic acid was proposed. Therefore, a mixture of peptides A and B was isolated by 
HPLC. After drying the sample, anhydrous 3 M HCl in MeOH was added and stirred at 
room temperature for 2 h to undergo esterification. The mixture was dried and analyzed 
by LC-MS (Figure 6-17 and 6-18). Based on MS analysis, both peptides’ MW increased 
by 28 Da corresponding to two methyl ester formations. Except for the C-terminal 
carboxylic acid, there are no carboxyl amino acid in peptides A and B and they must 
have come from the shunt intermediates. 
 
 
Figure 6-17. The MS and MS/MS analysis of peptide A after esterification. 
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Figure 6-18. The MS and MS/MS analysis of peptide B after esterification. 
 
 
 The identification of the carboxylic acid raised a question about oxygen 
incorporation. The assay was set up under an atmosphere of 18O2. The MS analysis of 
peptides A and B indicated two oxygen incorporations (Figure 6-19 and 6-20). 
Furthermore, peptides C and D showed three oxygen incorporations (Figure 6-21 and 6-
22). The results were very similar to the oxygen incorporation of keto-acid. Although the 
experiment using a mixture of 16O2 and 18O2 was not conducted, the results were 
predicted to be that the two oxygen atoms derive from two different oxygen gas. 
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Figure 6-19. The MS and MS/MS analysis of peptide A with two 18O incorporations. 
 
 
 
Figure 6-20. The MS and MS/MS analysis of peptide B with two 18O incorporations. 
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Figure 6-21. The MS and MS/MS analysis of peptide C with three 18O incorporations. 
 
 
 
Figure 6-22. The MS and MS/MS analysis of peptide D with three 18O incorporations. 
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Identification of +58 Da on Lys62 
 There are two peptide sequences with shunt intermediates. Peptides A and B 
comprise Ala63 to Lys71. Peptide A is +207 Da and peptide B is +209 Da compared to 
the original peptide. Based on the MS/MS spectra, both have a phosphate group. 
Interestingly, peptides D and E also have a phosphate group identified by the MS/MS 
spectra. They comprise residues Val57 to Lys71 and likely contain the same shunt 
intermediates at His66 that were in peptides A and B, but also include a modification at 
Lys62. If the modifications at His66 are identical, then peptides D and E both had an 
increase of 58 Da after subtracting the MW of the original peptides with 207 or 209 Da.  
 To identify the 58 Da structure at Lys62, the THI5p H66G mutant was used to 
investigate. After the reaction, the protein was digested with trypsin and analyzed by 
LC-MS (Figure 6-23). The EIC analysis was used to find a peptide between Val57 and 
Lys71 showing +58 Da. Based the MS and MS/MS analysis, the peptide can be 
identified. Interestingly, this structure was Lys62 with glyoxylate after an imine 
reduction. Although the mechanism of this modification is unknown, structural 
identification could be achieved. Glyoxylate was added to THI5p H66G followed by 
NaBH4 reduction. The resulting protein was digested followed by co-migration 
experiments. The retention time and MS/MS spectra were identical, confirming the 
structure. 
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Figure 6-23. (A) The EIC analysis of the peptide with +58 Da. (B) The MS analysis of 
the peptide with +58 Da. (C) The MS/MS analysis of peptide with +58 Da. (D) The 
MS/MS analysis of reference peptide generated by THI5p H66G+glyoxylate with 
NaBH4 reduction. 
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 I also attempted to characterize peptide C. The sequence of peptide C is the same 
as peptide D and E and I assumed that peptide C had +58 Da at Lys62. After subtracting 
58 Da and the original peptide MW, the MW shift was 5.96 Da. This MW shift is the 
result of the histidine-derived keto-acid. To characterize this peptide, the digested 
peptides were treated with NaBH4. The EIC analysis identified a peptide with +2 Da and 
the MS/MS spectrum confirmed the correct peptide sequence (Figure 6-24). This 
characterization indirectly solved the structure of peptide C. 
 
 
Figure 6-24. The MS and MS/MS analysis of peptide C after NaBH4 reduction. 
 
 
Conclusion 
 Based on the available information, the proposed structures of all five peptides 
are shown (Figure 6-25). Further research is required to characterize the structures. 
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Figure 6-25. The proposed structure of five peptides. 
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CHAPTER VII 
PRELIMINARY BIOPHYSICAL INVESTIGATION OF THI5 PROTEIN 
 
Introduction 
 The crystal structure of THI5p H66G with iron was obtained by Dr. Michael K. 
Fenwick in Dr. Ealick’s lab (Cornell University). The preliminary result of this structure 
showed that THI5p is a di-iron protein. Notably, there were no histidines among the 
residues coordinating to the metal. Typically non-heme iron dependent enzymes have at 
least one histidine as the metal ligand 32,33, such as in the well-known di-iron enzymes, 
methane monooxygenase 34 and ribonucleotide reductase R2 35, which each have one 
histidine for each iron. The absence of histidine presents the possibility that THI5p has a 
new iron coordinating environment to conduct HMP-P formation.  
 In this chapter, the oxygen consumption for HMP-P formation was measured and 
the preliminary EPR investigation of THI5p was conducted. 
 
 
Experimental methods 
Anaerobic overexpression of THI5p 
E. coli BL21(DE3) cells containing the THI5 gene in pET28b was grown in 
fermentor with nitrogen gas purge (the flow rate is 1 L/min). 10 L of growth medium 
contained 250 g of LB, 9.3 L of water, 500 mL of buffer stock (1 M Na2HPO4, 1 M 
KH2PO4, and 0.5 M (NH4)2SO4), 250 mL of sugar stock (20% glucose and 20% 
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glycerol), 20 mL of 1 M MgSO4, and 250 mL of 1 M sodium fumarate. Every stock 
solution was autoclaved separately. The medium contained kanamycin (100 µg/mL) 
with 50 rpm of stir at 37 oC until the OD600 reached 0.6. At this point, protein 
overexpression was induced with IPTG (final concentration of 1 mM), and cell growth 
was continued at 22 °C for 16 h. The cells were harvested and the protein was purified 
anaerobically. 
 
Determination of iron amount 
The active THI5p was prepared with the standard procedure in the glove box. 10 
µL of THI5p solution was added into 490 µL of water followed by the addition of 100 
µL of 2 M HCl and 100 µL of saturated ammonium acetate. The solution was incubated 
at 100 °C for 3 min. The resulting solution was centrifuged at 16000 rpm for 5 min. 600 
µL of the supernatant was removed and mixed with 20 µL of 10 mM ferrozine and 20 
µL of 100 mM ascorbic acid. After 10 min incubation, the absorbance was measured at 
562 nm (the extinction coefficient of iron ferrozine complex at 562 nm is 27.9           
mM-1cm-1).  
 
Oxygen consumption measurement 
The Oxygraph system (Hansatech instruments) was used to measure the oxygen 
concentration of the reaction mixture. The instrument installation and the calibration 
followed the manual description. The sample chamber contained 500 µL of air saturated 
buffer. 100 µL of the THI5p solution prepared in the glove box was injected into the 
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sample chamber. The oxygen concentration was recorded by the instrument. Because the 
THI5p solution was anaerobic, the final oxygen concentration was multiplied by 5/6 for 
the initial reading. Similarly the final concentration of THI5p would be 1/6 of the 
original. The calculation used the final concentration after mixing the anaerobic THI5p 
solution and air saturated buffer. 
 
TCEP oxidation in the THI5p C199A assays analyzed by 31P-NMR 
200 µL of THI5p C199A solution was anaerobically added into 500 µL of buffer 
(100 mM Tris-HCl, 2 mM TCEP, pH 7.5). The mixture was stirred at room temperature 
under 18O2 or 16O2 for 2 h. The mixture was put into an Amicon 10 KDa cut-off filter and 
centrifuged at 14000 rpm. 500 µL of filtrate was mixed with 60 µL of D2O and 3 µL of 6 
M HCl. 31P-signal of the solution was measured by Bruker 400 MHz. 
 
 
Results and discussion 
Oxygen consumption measurement of THI5p wild-type 
 In the previous chapters, the oxygen incorporation of the His66-derived keto-acid 
and PLP by-products were investigated using 18O2. Based on these results, the proposed 
mechanism of HMP-P formation included several oxygen requirements. Therefore, the 
change of oxygen concentration was measured by the Oxygraph system. 
 The active THI5p concentration was presumably determined by half the iron 
concentration because of the di-iron site. The iron concentration was measured by 
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Ferrozine assay. The change of oxygen concentration was divided by the active THI5p 
concentration to get the ratio corresponding to the total oxygen consumption per THI5p.  
 The full reaction assay of THI5p-WT was measured (Figure 7-1). The initial O2 
concentration was 250 µM. Because 100 µL of the THI5p oxygen free solution was 
added into 500 µL of air saturated buffer, the actual initial O2 concentration was 208.3 
µM. The final O2 concentration was 70 µM. The consumed oxygen was 133.3 µM. 
Moreover, the concentration of iron on THI5p was 27 µM determined by a Ferrozine 
assay. Based on the di-iron enzyme model, the amount of active THI5p was assumed to 
be 13.5 µM. Finally, the calculated ratio of the consumed oxygen to the active THI5p 
was 10.2.  
 
 
Figure 7-1. Measurement of oxygen consumption in THI5p-WT reaction. 
 
 
This result suggested that the THI5p full reaction uses multiple O2, which is 
different from any non-heme iron dependent oxygenase. Moreover, the proposed 
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mechanism showed four O2 for HMP-P formation, and C199 and M320 oxidation might 
require another four oxygen gas molecules. However, the metal-site chemistry is 
unknown and might react with oxygen to conduct the reaction as in ribonucleotide 
reductase R2. The unconventional chemistry is an interesting feature of the metal-site. 
 
Oxygen consumption measurement of THI5p C199A 
 Although the function of C199 is unclear, it is essential for HMP-P formation. 
Therefore, the measurement of oxygen consumption was conducted for the full reaction 
assay using the THI5p C199A mutant (Figure 7-2). Unexpectedly, this mutant consumed 
more oxygen than the wild-type to the point where it depleted all the oxygen gas in the 
reaction buffer. To test its reactivity, oxygen saturated buffer was added and monitored 
continuously. The result showed it consumed all the oxygen gas present in the buffer. 
This is currently perplexing, but it may be that C199 plays an important role in metal-
site chemistry. The cysteine is also required for function as the mutant cannot generate 
HMP-P and the di-iron site likely reacts with oxygen to conduct the reaction. 
 
 
Figure 7-2. The measurement of oxygen consumption in the THI5p C199A reaction. 
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TCEP oxidation investigation using THI5p C199A 
 THI5p C199A reacted with oxygen gas catalytically, but was unable to generate 
the product, HMP-P. Presumably, the mutation prevented oxygen from incorporating on 
the protein. The intact MW of THI5p-C199A after the reaction also showed no obvious 
modification. The high oxygen gas consumption of this protein indicates the generation 
of a product, but what product is it?  
 If O2 reacts with di-ferrous, it could generate hydrogen peroxide with the 
formation of di-ferric. Testing this hypothesis with the dye PO1 did not detect the 
formation of hydrogen peroxide 36. 
 Next, I tested for the reaction of Tris-(2-carboxyethyl) phosphine (TCEP) which 
can be oxidized. After the reaction, the protein was removed and the filtrate was 
analyzed by 31P-NMR 37 (Figure 7-3). The solution was adjusted to be acidic to make the 
TCEP signal visible. In the 31P-NMR spectra, the full reaction showed the formation of 
Tris-(2-carboxyethyl) phosphine oxide (TCEPO) compared with other two control 
reactions.  
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Figure 7-3. 31P-NMR monitoring oxidation of TCEP in THI5p C199A assays. 
 
 
However, there are two cysteine residues, C196 and C197, near the di-iron site 
that could form a disulfide bond. TCEP reacts with disulfide to regenerate free cysteine 
with formation of TCEPO. To differentiate between these two reactions, the assay was 
set up under an 18O2 atmosphere. If TCEPO is 18O-labeled, it suggests that the by-
product of O2 oxidizes TCEP. 31P-NMR spectra showed TCEPO with 18O incorporation 
(Figure 7-4). However, the ratio of 18O- and 16O-labeled TCEP was 0.12 (the expected 
ratio is 0.5).  
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Figure 7-4. 31P-NMR monitoring oxidation of TCEP in the THI5p C199A assays under 
atmosphere of 16O2 (bottom) and 18O2 (top). 
 
 
 The results did not match the proposed mechanism, but they could give some 
hints about the di-iron chemistry of THI5p. The oxidant derived from oxygen gas and di-
iron might allow the formation of a disulfide bond between C196 and C197. TCEP 
regenerates free cysteines with formation of TCEPO. 18O-TCEPO might derive from the 
shunt reaction where the oxidant reacts with TCEP before C196 and C197. Clearly the 
di-iron chemistry will require more advanced biophysical investigations before yielding 
conclusive results, such as EPR and Mössbauer spectroscopy.  
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UV and EPR investigation of THI5p+Fe with NaCN 
 In the di-iron enzyme after air exposure, there is a charge transfer band at 340 nm 
corresponding to di-ferric oxo-bridged 38. The addition of sodium azide would result in 
the formation of a chromophore with broad absorption bands at 345 and 450 nm, as 
observed for azide complexes and numerous other proteins containing oxo-bridged di-
iron clusters.  
 Since the preliminary crystal structure of THI5p with iron suggested that it is a 
non-heme di-iron enzyme, similar investigations were applied. Because the PLP UV-Vis 
spectrum overlaps below 400 nm, it would be difficult to interpret the data, hence the 
addition of sodium azide was tested to generate a UV-Vis shift. However, no new charge 
transfer band was generated around 450 nm after adding sodium azide at 1 M final 
concentration. The lack of change might be due to a different coordinating environment, 
so a stronger ligand, cyanide, was tested. After exposing the air, sodium cyanide was 
added to the THI5p+Fe solution and, surprisingly, the solution became pink within 
seconds. The solution remained pink despite desalting to remove any small molecules 
implying that cyanide coordinates to iron. The UV-Vis spectrum of this solution was 
measured and λmax was about 720 nm (Figure 7-5). The known cyanide bridged iron 
complex is Prussian Blue with broad absorbance about 600 nm. The oxidation state of 
di-iron is Fe(II) and Fe(III). Furthermore, the solution color did not change as drastically 
if THI5p+Fe was not exposed to air before the addition of sodium cyanide. Finally, this 
pink protein sample was measured by EPR. The g value was 2.11. But the typical di-iron 
enzyme has the g value below 2. 
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Figure 7-5. UV-Vis spectra of NaCN adding samples. 
 
 
 
Figure 7-6. EPR measurement of THI5p+Fe(II)+O2 with NaCN addition. 
 
 
Conclusion 
 In this chapter, the preliminary investigation for the metal site was conducted. 
Although it could not fully interpret the bioinorganic chemistry, it was a starting point 
for the future investigation.  
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CHAPTER VIII 
 CONCLUSION AND PERSPECTIVE 
 
Conclusion 
 Thiamin is a fascinating cofactor to investigate. In my first project with ThiG, the 
work was to use the reverse reaction to study later steps of bacterial thiazole 
biosynthesis. In my second project, the THI5p activity was reconstituted successfully. 
The chemical equation of HMP-P formation catalyzed by THI5p was completed (Figure 
8-1).  
 
 
Figure 8-1. Summary of THI5p investigation 
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This enzymatic reaction requires 10 to 11 eq. of O2 to generate HMP-P and 
oxygen incorporates into the His66-derived keto-acid 8-4 and glyoxylate 8-5. Moreover, 
Cys199 and Met320 are oxidized after HMP-P formation. These are all unprecedented 
results. 2-oxo-histidine 8-9 and PLP-nitrile 8-10 were characterized to demonstrate the 
proposed mechanism. 
 
Perspective 
 The mechanistic investigation of THI5p has been a challenge. In chapter 6, four 
peptides containing intermediates were identified. But LC-MS analysis provides only the 
peptide sequence information and the MW of the intermediates, it does not solve the 
structures. To characterize the intermediate structures, the purification of these peptides 
will be required followed by NMR analysis. 
 Next, the crystal structures of active THI5p+Fe and inactive THI5p are necessary 
to support investigation into the reaction mechanism. For inactive THI5p, it could 
compare with all of modification in the protein, e.g. the His66-derived keto-acid, Cys199 
sulfonic acid, and Met320 sulfoxide (Figure 8-1). I have conducted preliminary 
crystallizing screening and formed some preliminary crystals, however, the best 
resolution obtained was about 3.5 Å. The active THI5p+Fe(II) crystal structure will be 
useful for biophysical investigations, e.g. EPR, because the simulation of the spectra 
requires structural information to yield an accurate interpretation. The tentative ligands 
for iron do not have any histidine which is present in all other non-heme iron dependent 
enzymes. 
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 For the mechanistic investigation, PLP analogues could be applied to divert the 
reaction by the formation of shunt intermediates. Analogues 8-11 to 8-15 (Figure 8-2) 
made by Dr. Dmytro Fedoseyenko were tested. The preliminary results suggested that 8-
11 and 8-15 might generate some shunt intermediates based on intact protein MW 
measurements. Based on these results, it will be interesting to use halogenated PLP at 
the C2 position, e.g. 8-16 and 8-17, to generate more shunt intermediates.  
 
 
Figure 8-2. The PLP analogues for THI5p mechanistic investigations. The substrates 
were synthesized by Dr. Dmytro Fedoseyenko. 
 
 
 Other experiments were also conducted to try to obtain shunt intermediates in 
vivo. Dephosphorylated 8-11 and 8-13 were added to the growth media when THI5p was 
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11 seems to be reduced to PLP in vivo. Therefore, the purified THI5p was similar to the 
inactive THI5p from the in vitro assays. This would require dephosphorylated 8-15 to 
test because the in vitro assays showed that it might form shunt intermediates. The 
advantage to this approach is that that dephosphorylated PLP analogues can be used and 
the phosphorylation step during the synthesis can be skipped. The experimental analysis 
is also simpler because there is no co-purified PLP on THI5p. Another possible 
experiment is to use histidine analogues. Therefore, the possible approach is to use the 
pyrrolysyl-tRNA synthetase/tRNAPyl pair to incorporate unnatural histidine at His66 39.  
 Lastly, the investigations of the THI5p secondary function could be conducted. 
Preliminary studies could start by determining the ratio of thiamin and THI5p. 
Furthermore, phenotype of S. cerevisiae ΔTHI5 could be observed with thiamin 
supplementation. Moreover, it might be possible that THI5p has interacting proteins in 
vivo as the assays showed that THI5p used about 10 equivalents of O2 to generate HMP-
P and caused protein oxidation. In in vivo, other proteins might interact with THI5p to 
control the reaction efficiently, making finding these proteins an attractive avenue of 
research.   
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APPENDIX A 
 
 
 
1H- (Top) and 13C- (Bottom) NMR of 4-6 
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1H- (Top) and 13C- (Bottom) NMR of 4-7 
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1H- (Top) and 13C- (Bottom) NMR of 4-8 
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1H- (Top) and 13C- (Bottom) NMR of 4-9 
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1H- (Top) and 13C- (Bottom) NMR of glyoxylate derivatized by phenylhydrazine 
